CA2601243A1

CA2601243A1 - Methodes et composition relatives a l'imagerie in vivo d'une expression genique

Methodes et composition relatives a l'imagerie in vivo d'une expression genique Download PDF

Info

Publication number: CA2601243A1
Authority: CA; Canada
Prior art keywords: promoter sequence; promoter; nucleic acid; sequence; cell
Prior art date: 2005-03-09
Legal status : Abandoned

Application number

CA002601243A

Other languages

English (en)

Inventor

Vikas Kundra

Bingliang Fang

Lin X. Ji

Dan Yang

Current Assignee

University of Texas System

Original Assignee

Individual

Priority date

2005-03-09

Filing date

2006-03-09

Publication date

2006-09-21

2006-03-09 Application filed by Individual filed Critical Individual

2006-09-21 Publication of CA2601243A1 publication Critical patent/CA2601243A1/fr

Status Abandoned legal-status Critical Current

Links

230000014509 gene expression Effects 0.000 title claims abstract description 208
238000000034 method Methods 0.000 title claims abstract description 133
239000000203 mixture Substances 0.000 title description 31
238000011503 in vivo imaging Methods 0.000 title description 5
108090000623 proteins and genes Proteins 0.000 claims abstract description 228
206010028980 Neoplasm Diseases 0.000 claims abstract description 211
238000003384 imaging method Methods 0.000 claims abstract description 193
150000007523 nucleic acids Chemical group 0.000 claims abstract description 184
102000039446 nucleic acids Human genes 0.000 claims abstract description 146
108020004707 nucleic acids Proteins 0.000 claims abstract description 146
230000001225 therapeutic effect Effects 0.000 claims abstract description 102
201000011510 cancer Diseases 0.000 claims abstract description 60
238000001727 in vivo Methods 0.000 claims abstract description 42
108091006027 G proteins Proteins 0.000 claims abstract description 14
102000030782 GTP binding Human genes 0.000 claims abstract description 14
108091000058 GTP-Binding Proteins 0.000 claims abstract description 14
238000009206 nuclear medicine Methods 0.000 claims abstract description 7
210000004027 cell Anatomy 0.000 claims description 325
210000001519 tissue Anatomy 0.000 claims description 139
101000655352 Homo sapiens Telomerase reverse transcriptase Proteins 0.000 claims description 68
102000005962 receptors Human genes 0.000 claims description 58
108020003175 receptors Proteins 0.000 claims description 58
108090000586 somatostatin receptor 2 Proteins 0.000 claims description 51
239000003446 ligand Substances 0.000 claims description 49
-1 Ainilin Proteins 0.000 claims description 48
102000004169 proteins and genes Human genes 0.000 claims description 48
102000004052 somatostatin receptor 2 Human genes 0.000 claims description 46
108090000765 processed proteins & peptides Proteins 0.000 claims description 45
235000018102 proteins Nutrition 0.000 claims description 45
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 41
108091026890 Coding region Proteins 0.000 claims description 40
201000010099 disease Diseases 0.000 claims description 39
150000001413 amino acids Chemical group 0.000 claims description 37
239000003550 marker Substances 0.000 claims description 37
108010017842 Telomerase Proteins 0.000 claims description 34
108091023040 Transcription factor Proteins 0.000 claims description 34
230000027455 binding Effects 0.000 claims description 34
102000040945 Transcription factor Human genes 0.000 claims description 33
102000004196 processed proteins & peptides Human genes 0.000 claims description 33
108050001286 Somatostatin Receptor Proteins 0.000 claims description 32
102000011096 Somatostatin receptor Human genes 0.000 claims description 32
108091028043 Nucleic acid sequence Proteins 0.000 claims description 30
229920001184 polypeptide Polymers 0.000 claims description 29
108020004414 DNA Proteins 0.000 claims description 28
241000701022 Cytomegalovirus Species 0.000 claims description 27
239000003814 drug Substances 0.000 claims description 27
238000012384 transportation and delivery Methods 0.000 claims description 24
230000003612 virological effect Effects 0.000 claims description 23
241000700605 Viruses Species 0.000 claims description 19
230000003321 amplification Effects 0.000 claims description 19
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 18
238000003199 nucleic acid amplification method Methods 0.000 claims description 18
239000000126 substance Substances 0.000 claims description 18
210000004881 tumor cell Anatomy 0.000 claims description 18
239000002502 liposome Substances 0.000 claims description 17
101001061518 Homo sapiens RNA-binding protein FUS Proteins 0.000 claims description 15
101000659267 Homo sapiens Tumor suppressor candidate 2 Proteins 0.000 claims description 15
230000002950 deficient Effects 0.000 claims description 15
150000002632 lipids Chemical class 0.000 claims description 15
238000012634 optical imaging Methods 0.000 claims description 15
229940024606 amino acid Drugs 0.000 claims description 14
239000005090 green fluorescent protein Substances 0.000 claims description 14
210000004185 liver Anatomy 0.000 claims description 14
108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 13
108010043121 Green Fluorescent Proteins Proteins 0.000 claims description 13
102000004144 Green Fluorescent Proteins Human genes 0.000 claims description 13
102100028469 RNA-binding protein FUS Human genes 0.000 claims description 13
102000004190 Enzymes Human genes 0.000 claims description 12
108090000790 Enzymes Proteins 0.000 claims description 12
238000012217 deletion Methods 0.000 claims description 12
230000037430 deletion Effects 0.000 claims description 12
229940088598 enzyme Drugs 0.000 claims description 12
239000013612 plasmid Substances 0.000 claims description 12
210000002307 prostate Anatomy 0.000 claims description 12
230000011664 signaling Effects 0.000 claims description 12
210000003932 urinary bladder Anatomy 0.000 claims description 12
239000003981 vehicle Substances 0.000 claims description 12
102000001742 Tumor Suppressor Proteins Human genes 0.000 claims description 11
108010040002 Tumor Suppressor Proteins Proteins 0.000 claims description 11
108060008724 Tyrosinase Proteins 0.000 claims description 11
102000003425 Tyrosinase Human genes 0.000 claims description 11
230000006907 apoptotic process Effects 0.000 claims description 11
229940079593 drug Drugs 0.000 claims description 11
108010017007 glucose-regulated proteins Proteins 0.000 claims description 11
210000003734 kidney Anatomy 0.000 claims description 11
210000004072 lung Anatomy 0.000 claims description 11
210000005170 neoplastic cell Anatomy 0.000 claims description 11
238000001356 surgical procedure Methods 0.000 claims description 10
241001430294 unidentified retrovirus Species 0.000 claims description 10
101710082439 Hemagglutinin A Proteins 0.000 claims description 9
102000004877 Insulin Human genes 0.000 claims description 9
108090001061 Insulin Proteins 0.000 claims description 9
210000004556 brain Anatomy 0.000 claims description 9
229940088597 hormone Drugs 0.000 claims description 9
239000005556 hormone Substances 0.000 claims description 9
229940125396 insulin Drugs 0.000 claims description 9
230000004044 response Effects 0.000 claims description 9
210000003462 vein Anatomy 0.000 claims description 9
DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 claims description 8
102100023635 Alpha-fetoprotein Human genes 0.000 claims description 8
102100025475 Carcinoembryonic antigen-related cell adhesion molecule 5 Human genes 0.000 claims description 8
108060001084 Luciferase Proteins 0.000 claims description 8
239000005089 Luciferase Substances 0.000 claims description 8
102000003792 Metallothionein Human genes 0.000 claims description 8
108090000157 Metallothionein Proteins 0.000 claims description 8
108010069196 Neural Cell Adhesion Molecules Proteins 0.000 claims description 8
102100023616 Neural cell adhesion molecule L1-like protein Human genes 0.000 claims description 8
102000016387 Pancreatic elastase Human genes 0.000 claims description 8
108010067372 Pancreatic elastase Proteins 0.000 claims description 8
108010038512 Platelet-Derived Growth Factor Proteins 0.000 claims description 8
102000010780 Platelet-Derived Growth Factor Human genes 0.000 claims description 8
108010071690 Prealbumin Proteins 0.000 claims description 8
102000006601 Thymidine Kinase Human genes 0.000 claims description 8
108020004440 Thymidine kinase Proteins 0.000 claims description 8
102100029290 Transthyretin Human genes 0.000 claims description 8
102000034287 fluorescent proteins Human genes 0.000 claims description 8
108091006047 fluorescent proteins Proteins 0.000 claims description 8
238000004611 spectroscopical analysis Methods 0.000 claims description 8
102000007469 Actins Human genes 0.000 claims description 7
108010085238 Actins Proteins 0.000 claims description 7
108010062347 HLA-DQ Antigens Proteins 0.000 claims description 7
102000043131 MHC class II family Human genes 0.000 claims description 7
108091054438 MHC class II family Proteins 0.000 claims description 7
108010059343 MM Form Creatine Kinase Proteins 0.000 claims description 7
210000000481 breast Anatomy 0.000 claims description 7
210000001072 colon Anatomy 0.000 claims description 7
210000000952 spleen Anatomy 0.000 claims description 7
239000013603 viral vector Substances 0.000 claims description 7
102100027499 5-hydroxytryptamine receptor 1B Human genes 0.000 claims description 6
101710138639 5-hydroxytryptamine receptor 1B Proteins 0.000 claims description 6
102100022718 Atypical chemokine receptor 2 Human genes 0.000 claims description 6
102100038018 Corticotropin-releasing factor receptor 1 Human genes 0.000 claims description 6
101000678892 Homo sapiens Atypical chemokine receptor 2 Proteins 0.000 claims description 6
102000008394 Immunoglobulin Fragments Human genes 0.000 claims description 6
108010021625 Immunoglobulin Fragments Proteins 0.000 claims description 6
108010002350 Interleukin-2 Proteins 0.000 claims description 6
108010072866 Prostate-Specific Antigen Proteins 0.000 claims description 6
102100038358 Prostate-specific antigen Human genes 0.000 claims description 6
238000011319 anticancer therapy Methods 0.000 claims description 6
229960004015 calcitonin Drugs 0.000 claims description 6
239000003102 growth factor Substances 0.000 claims description 6
210000002216 heart Anatomy 0.000 claims description 6
239000000411 inducer Substances 0.000 claims description 6
208000020816 lung neoplasm Diseases 0.000 claims description 6
210000001165 lymph node Anatomy 0.000 claims description 6
210000002569 neuron Anatomy 0.000 claims description 6
210000001672 ovary Anatomy 0.000 claims description 6
210000000496 pancreas Anatomy 0.000 claims description 6
238000012360 testing method Methods 0.000 claims description 6
210000001685 thyroid gland Anatomy 0.000 claims description 6
238000002604 ultrasonography Methods 0.000 claims description 6
102000009027 Albumins Human genes 0.000 claims description 5
108010088751 Albumins Proteins 0.000 claims description 5
102000055006 Calcitonin Human genes 0.000 claims description 5
108060001064 Calcitonin Proteins 0.000 claims description 5
102000015554 Dopamine receptor Human genes 0.000 claims description 5
108050004812 Dopamine receptor Proteins 0.000 claims description 5
102100028501 Galanin peptides Human genes 0.000 claims description 5
206010062767 Hypophysitis Diseases 0.000 claims description 5
102000003996 Interferon-beta Human genes 0.000 claims description 5
108090000467 Interferon-beta Proteins 0.000 claims description 5
206010058467 Lung neoplasm malignant Diseases 0.000 claims description 5
108010071563 Proto-Oncogene Proteins c-fos Proteins 0.000 claims description 5
102000007568 Proto-Oncogene Proteins c-fos Human genes 0.000 claims description 5
108020004459 Small interfering RNA Proteins 0.000 claims description 5
210000004100 adrenal gland Anatomy 0.000 claims description 5
108010026331 alpha-Fetoproteins Proteins 0.000 claims description 5
210000000709 aorta Anatomy 0.000 claims description 5
210000001367 artery Anatomy 0.000 claims description 5
230000001580 bacterial effect Effects 0.000 claims description 5
210000000988 bone and bone Anatomy 0.000 claims description 5
210000001185 bone marrow Anatomy 0.000 claims description 5
210000004899 c-terminal region Anatomy 0.000 claims description 5
BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 claims description 5
210000001736 capillary Anatomy 0.000 claims description 5
210000004534 cecum Anatomy 0.000 claims description 5
210000001638 cerebellum Anatomy 0.000 claims description 5
210000004720 cerebrum Anatomy 0.000 claims description 5
210000001198 duodenum Anatomy 0.000 claims description 5
210000003238 esophagus Anatomy 0.000 claims description 5
210000003527 eukaryotic cell Anatomy 0.000 claims description 5
210000001508 eye Anatomy 0.000 claims description 5
210000000232 gallbladder Anatomy 0.000 claims description 5
239000000122 growth hormone Substances 0.000 claims description 5
210000003405 ileum Anatomy 0.000 claims description 5
210000000936 intestine Anatomy 0.000 claims description 5
210000001630 jejunum Anatomy 0.000 claims description 5
210000000867 larynx Anatomy 0.000 claims description 5
210000000265 leukocyte Anatomy 0.000 claims description 5
201000005202 lung cancer Diseases 0.000 claims description 5
210000005075 mammary gland Anatomy 0.000 claims description 5
210000003205 muscle Anatomy 0.000 claims description 5
210000000107 myocyte Anatomy 0.000 claims description 5
210000001328 optic nerve Anatomy 0.000 claims description 5
210000002990 parathyroid gland Anatomy 0.000 claims description 5
210000003899 penis Anatomy 0.000 claims description 5
210000003800 pharynx Anatomy 0.000 claims description 5
210000003635 pituitary gland Anatomy 0.000 claims description 5
210000002975 pon Anatomy 0.000 claims description 5
210000003079 salivary gland Anatomy 0.000 claims description 5
210000001625 seminal vesicle Anatomy 0.000 claims description 5
210000002027 skeletal muscle Anatomy 0.000 claims description 5
210000003491 skin Anatomy 0.000 claims description 5
210000002460 smooth muscle Anatomy 0.000 claims description 5
210000000278 spinal cord Anatomy 0.000 claims description 5
210000002784 stomach Anatomy 0.000 claims description 5
210000001550 testis Anatomy 0.000 claims description 5
210000001541 thymus gland Anatomy 0.000 claims description 5
210000003437 trachea Anatomy 0.000 claims description 5
210000004291 uterus Anatomy 0.000 claims description 5
210000001215 vagina Anatomy 0.000 claims description 5
201000010653 vesiculitis Diseases 0.000 claims description 5
102000000546 Apoferritins Human genes 0.000 claims description 4
108010002084 Apoferritins Proteins 0.000 claims description 4
208000003174 Brain Neoplasms Diseases 0.000 claims description 4
206010006187 Breast cancer Diseases 0.000 claims description 4
208000026310 Breast neoplasm Diseases 0.000 claims description 4
102100025074 C-C chemokine receptor-like 2 Human genes 0.000 claims description 4
102000012422 Collagen Type I Human genes 0.000 claims description 4
108010022452 Collagen Type I Proteins 0.000 claims description 4
102000029816 Collagenase Human genes 0.000 claims description 4
108060005980 Collagenase Proteins 0.000 claims description 4
241000702421 Dependoparvovirus Species 0.000 claims description 4
206010013801 Duchenne Muscular Dystrophy Diseases 0.000 claims description 4
108700041152 Endoplasmic Reticulum Chaperone BiP Proteins 0.000 claims description 4
102100021451 Endoplasmic reticulum chaperone BiP Human genes 0.000 claims description 4
241000713813 Gibbon ape leukemia virus Species 0.000 claims description 4
108010051696 Growth Hormone Proteins 0.000 claims description 4
108010067802 HLA-DR alpha-Chains Proteins 0.000 claims description 4
101150112743 HSPA5 gene Proteins 0.000 claims description 4
241000700721 Hepatitis B virus Species 0.000 claims description 4
108010068250 Herpes Simplex Virus Protein Vmw65 Proteins 0.000 claims description 4
108010033040 Histones Proteins 0.000 claims description 4
101000829127 Homo sapiens Somatostatin receptor type 2 Proteins 0.000 claims description 4
102000006496 Immunoglobulin Heavy Chains Human genes 0.000 claims description 4
108010019476 Immunoglobulin Heavy Chains Proteins 0.000 claims description 4
102000013463 Immunoglobulin Light Chains Human genes 0.000 claims description 4
108010065825 Immunoglobulin Light Chains Proteins 0.000 claims description 4
108090001117 Insulin-Like Growth Factor II Proteins 0.000 claims description 4
102400000022 Insulin-like growth factor II Human genes 0.000 claims description 4
102000010789 Interleukin-2 Receptors Human genes 0.000 claims description 4
108010038453 Interleukin-2 Receptors Proteins 0.000 claims description 4
206010033128 Ovarian cancer Diseases 0.000 claims description 4
241001631646 Papillomaviridae Species 0.000 claims description 4
102000004005 Prostaglandin-endoperoxide synthases Human genes 0.000 claims description 4
108090000459 Prostaglandin-endoperoxide synthases Proteins 0.000 claims description 4
206010060862 Prostate cancer Diseases 0.000 claims description 4
208000000236 Prostatic Neoplasms Diseases 0.000 claims description 4
101100111629 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) KAR2 gene Proteins 0.000 claims description 4
102100038803 Somatotropin Human genes 0.000 claims description 4
108091008874 T cell receptors Proteins 0.000 claims description 4
102000016266 T-Cell Antigen Receptors Human genes 0.000 claims description 4
102000013394 Troponin I Human genes 0.000 claims description 4
108010065729 Troponin I Proteins 0.000 claims description 4
GXBMIBRIOWHPDT-UHFFFAOYSA-N Vasopressin Natural products N1C(=O)C(CC=2C=C(O)C=CC=2)NC(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C1CC1=CC=CC=C1 GXBMIBRIOWHPDT-UHFFFAOYSA-N 0.000 claims description 4
239000002253 acid Substances 0.000 claims description 4
KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 claims description 4
230000004700 cellular uptake Effects 0.000 claims description 4
229940107137 cholecystokinin Drugs 0.000 claims description 4
229960002424 collagenase Drugs 0.000 claims description 4
101150028578 grp78 gene Proteins 0.000 claims description 4
230000001900 immune effect Effects 0.000 claims description 4
229960001438 immunostimulant agent Drugs 0.000 claims description 4
239000003022 immunostimulating agent Substances 0.000 claims description 4
230000003308 immunostimulating effect Effects 0.000 claims description 4
210000005036 nerve Anatomy 0.000 claims description 4
208000008443 pancreatic carcinoma Diseases 0.000 claims description 4
238000002601 radiography Methods 0.000 claims description 4
210000000664 rectum Anatomy 0.000 claims description 4
210000003705 ribosome Anatomy 0.000 claims description 4
210000002966 serum Anatomy 0.000 claims description 4
IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 claims description 4
229960003726 vasopressin Drugs 0.000 claims description 4
ARLKVQYMFRECLV-JSGCOSHPSA-N (2s)-2-[[(2s)-2-amino-3-(1h-indol-3-yl)propanoyl]amino]-4-methylsulfanylbutanamide Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](CCSC)C(N)=O)=CNC2=C1 ARLKVQYMFRECLV-JSGCOSHPSA-N 0.000 claims description 3
102100022738 5-hydroxytryptamine receptor 1A Human genes 0.000 claims description 3
101710138638 5-hydroxytryptamine receptor 1A Proteins 0.000 claims description 3
102100027493 5-hydroxytryptamine receptor 1D Human genes 0.000 claims description 3
101710138068 5-hydroxytryptamine receptor 1D Proteins 0.000 claims description 3
102100036311 5-hydroxytryptamine receptor 1F Human genes 0.000 claims description 3
101710138086 5-hydroxytryptamine receptor 1F Proteins 0.000 claims description 3
102100024959 5-hydroxytryptamine receptor 2C Human genes 0.000 claims description 3
101710138093 5-hydroxytryptamine receptor 2C Proteins 0.000 claims description 3
102100040385 5-hydroxytryptamine receptor 4 Human genes 0.000 claims description 3
101710150225 5-hydroxytryptamine receptor 4 Proteins 0.000 claims description 3
102100040370 5-hydroxytryptamine receptor 5A Human genes 0.000 claims description 3
101710138069 5-hydroxytryptamine receptor 5A Proteins 0.000 claims description 3
101710138071 5-hydroxytryptamine receptor 5B Proteins 0.000 claims description 3
101710150235 5-hydroxytryptamine receptor 6 Proteins 0.000 claims description 3
101710150237 5-hydroxytryptamine receptor 7 Proteins 0.000 claims description 3
102100039126 5-hydroxytryptamine receptor 7 Human genes 0.000 claims description 3
102000040125 5-hydroxytryptamine receptor family Human genes 0.000 claims description 3
108091032151 5-hydroxytryptamine receptor family Proteins 0.000 claims description 3
102000009346 Adenosine receptors Human genes 0.000 claims description 3
108050000203 Adenosine receptors Proteins 0.000 claims description 3
108060003345 Adrenergic Receptor Proteins 0.000 claims description 3
102000017910 Adrenergic receptor Human genes 0.000 claims description 3
102000008873 Angiotensin II receptor Human genes 0.000 claims description 3
108050000824 Angiotensin II receptor Proteins 0.000 claims description 3
102100021663 Baculoviral IAP repeat-containing protein 5 Human genes 0.000 claims description 3
206010005003 Bladder cancer Diseases 0.000 claims description 3
206010005949 Bone cancer Diseases 0.000 claims description 3
208000018084 Bone neoplasm Diseases 0.000 claims description 3
102000010183 Bradykinin receptor Human genes 0.000 claims description 3
108050001736 Bradykinin receptor Proteins 0.000 claims description 3
102100031151 C-C chemokine receptor type 2 Human genes 0.000 claims description 3
101710149815 C-C chemokine receptor type 2 Proteins 0.000 claims description 3
102100024167 C-C chemokine receptor type 3 Human genes 0.000 claims description 3
101710149862 C-C chemokine receptor type 3 Proteins 0.000 claims description 3
101710149863 C-C chemokine receptor type 4 Proteins 0.000 claims description 3
102100035875 C-C chemokine receptor type 5 Human genes 0.000 claims description 3
101710149870 C-C chemokine receptor type 5 Proteins 0.000 claims description 3
102100036301 C-C chemokine receptor type 7 Human genes 0.000 claims description 3
102100036305 C-C chemokine receptor type 8 Human genes 0.000 claims description 3
102100021942 C-C motif chemokine 28 Human genes 0.000 claims description 3
102100028989 C-X-C chemokine receptor type 2 Human genes 0.000 claims description 3
102100028990 C-X-C chemokine receptor type 3 Human genes 0.000 claims description 3
102100031650 C-X-C chemokine receptor type 4 Human genes 0.000 claims description 3
102100031658 C-X-C chemokine receptor type 5 Human genes 0.000 claims description 3
108091005932 CCKBR Proteins 0.000 claims description 3
108010078311 Calcitonin Gene-Related Peptide Receptors Proteins 0.000 claims description 3
102000014468 Calcitonin Gene-Related Peptide Receptors Human genes 0.000 claims description 3
102100035418 Ceramide synthase 4 Human genes 0.000 claims description 3
206010008342 Cervix carcinoma Diseases 0.000 claims description 3
102000009410 Chemokine receptor Human genes 0.000 claims description 3
108050000299 Chemokine receptor Proteins 0.000 claims description 3
108010035563 Chloramphenicol O-acetyltransferase Proteins 0.000 claims description 3
108010089448 Cholecystokinin B Receptor Proteins 0.000 claims description 3
102000004859 Cholecystokinin Receptors Human genes 0.000 claims description 3
108090001085 Cholecystokinin Receptors Proteins 0.000 claims description 3
108010009685 Cholinergic Receptors Proteins 0.000 claims description 3
206010009944 Colon cancer Diseases 0.000 claims description 3
108010056643 Corticotropin-Releasing Hormone Receptors Proteins 0.000 claims description 3
102100038019 Corticotropin-releasing factor receptor 2 Human genes 0.000 claims description 3
108700010025 DRD1 Proteins 0.000 claims description 3
108010063774 E2F1 Transcription Factor Proteins 0.000 claims description 3
102100039328 Endoplasmin Human genes 0.000 claims description 3
102000010180 Endothelin receptor Human genes 0.000 claims description 3
108050001739 Endothelin receptor Proteins 0.000 claims description 3
208000000461 Esophageal Neoplasms Diseases 0.000 claims description 3
102100021243 G-protein coupled receptor 182 Human genes 0.000 claims description 3
101150037782 GAL2 gene Proteins 0.000 claims description 3
101150103804 GAL3 gene Proteins 0.000 claims description 3
102000011392 Galanin receptor Human genes 0.000 claims description 3
108050001605 Galanin receptor Proteins 0.000 claims description 3
102100021735 Galectin-2 Human genes 0.000 claims description 3
102100039558 Galectin-3 Human genes 0.000 claims description 3
102000052874 Gastrin receptors Human genes 0.000 claims description 3
102000018899 Glutamate Receptors Human genes 0.000 claims description 3
108010027915 Glutamate Receptors Proteins 0.000 claims description 3
101100167640 Glycine max CLV1B gene Proteins 0.000 claims description 3
102000017357 Glycoprotein hormone receptor Human genes 0.000 claims description 3
108050005395 Glycoprotein hormone receptor Proteins 0.000 claims description 3
102100021519 Hemoglobin subunit beta Human genes 0.000 claims description 3
108091005904 Hemoglobin subunit beta Proteins 0.000 claims description 3
102000000543 Histamine Receptors Human genes 0.000 claims description 3
108010002059 Histamine Receptors Proteins 0.000 claims description 3
101000946384 Homo sapiens Alpha-lactalbumin Proteins 0.000 claims description 3
101000777558 Homo sapiens C-C chemokine receptor type 10 Proteins 0.000 claims description 3
101000716068 Homo sapiens C-C chemokine receptor type 6 Proteins 0.000 claims description 3
101000716065 Homo sapiens C-C chemokine receptor type 7 Proteins 0.000 claims description 3
101000716063 Homo sapiens C-C chemokine receptor type 8 Proteins 0.000 claims description 3
101000716070 Homo sapiens C-C chemokine receptor type 9 Proteins 0.000 claims description 3
101000897477 Homo sapiens C-C motif chemokine 28 Proteins 0.000 claims description 3
101000916050 Homo sapiens C-X-C chemokine receptor type 3 Proteins 0.000 claims description 3
101000922348 Homo sapiens C-X-C chemokine receptor type 4 Proteins 0.000 claims description 3
101000922405 Homo sapiens C-X-C chemokine receptor type 5 Proteins 0.000 claims description 3
101100005713 Homo sapiens CD4 gene Proteins 0.000 claims description 3
101000737544 Homo sapiens Ceramide synthase 4 Proteins 0.000 claims description 3
101000878678 Homo sapiens Corticotropin-releasing factor receptor 1 Proteins 0.000 claims description 3
101000878664 Homo sapiens Corticotropin-releasing factor receptor 2 Proteins 0.000 claims description 3
101100343328 Homo sapiens LIMK2 gene Proteins 0.000 claims description 3
101000966782 Homo sapiens Lysophosphatidic acid receptor 1 Proteins 0.000 claims description 3
101000603877 Homo sapiens Nuclear receptor subfamily 1 group I member 2 Proteins 0.000 claims description 3
101001120087 Homo sapiens P2Y purinoceptor 11 Proteins 0.000 claims description 3
101000613565 Homo sapiens PRKC apoptosis WT1 regulator protein Proteins 0.000 claims description 3
101001135199 Homo sapiens Partitioning defective 3 homolog Proteins 0.000 claims description 3
101001098529 Homo sapiens Proteinase-activated receptor 1 Proteins 0.000 claims description 3
101001098560 Homo sapiens Proteinase-activated receptor 2 Proteins 0.000 claims description 3
101001098557 Homo sapiens Proteinase-activated receptor 3 Proteins 0.000 claims description 3
101001113471 Homo sapiens Proteinase-activated receptor 4 Proteins 0.000 claims description 3
101000713170 Homo sapiens Solute carrier family 52, riboflavin transporter, member 1 Proteins 0.000 claims description 3
101000713169 Homo sapiens Solute carrier family 52, riboflavin transporter, member 2 Proteins 0.000 claims description 3
101000829138 Homo sapiens Somatostatin receptor type 3 Proteins 0.000 claims description 3
101000829153 Homo sapiens Somatostatin receptor type 5 Proteins 0.000 claims description 3
101000666868 Homo sapiens Vasoactive intestinal polypeptide receptor 2 Proteins 0.000 claims description 3
241000725303 Human immunodeficiency virus Species 0.000 claims description 3
108010018951 Interleukin-8B Receptors Proteins 0.000 claims description 3
208000008839 Kidney Neoplasms Diseases 0.000 claims description 3
206010025323 Lymphomas Diseases 0.000 claims description 3
102000016994 Lysolipids receptors Human genes 0.000 claims description 3
102100040607 Lysophosphatidic acid receptor 1 Human genes 0.000 claims description 3
108010027749 Lysophospholipid Receptors Proteins 0.000 claims description 3
102000001419 Melatonin receptor Human genes 0.000 claims description 3
108050009605 Melatonin receptor Proteins 0.000 claims description 3
108010008707 Mucin-1 Proteins 0.000 claims description 3
102100034256 Mucin-1 Human genes 0.000 claims description 3
241001529936 Murinae Species 0.000 claims description 3
101100007124 Mus musculus Col11a2 gene Proteins 0.000 claims description 3
101000844719 Mus musculus Deleted in malignant brain tumors 1 protein Proteins 0.000 claims description 3
PRQROPMIIGLWRP-UHFFFAOYSA-N N-formyl-methionyl-leucyl-phenylalanin Chemical compound CSCCC(NC=O)C(=O)NC(CC(C)C)C(=O)NC(C(O)=O)CC1=CC=CC=C1 PRQROPMIIGLWRP-UHFFFAOYSA-N 0.000 claims description 3
108050002826 Neuropeptide Y Receptor Proteins 0.000 claims description 3
102000012301 Neuropeptide Y receptor Human genes 0.000 claims description 3
206010030155 Oesophageal carcinoma Diseases 0.000 claims description 3
108700020796 Oncogene Proteins 0.000 claims description 3
206010061535 Ovarian neoplasm Diseases 0.000 claims description 3
102000004279 Oxytocin receptors Human genes 0.000 claims description 3
108090000876 Oxytocin receptors Proteins 0.000 claims description 3
102100037600 P2Y purinoceptor 1 Human genes 0.000 claims description 3
108050008996 P2Y purinoceptor 1 Proteins 0.000 claims description 3
102100026172 P2Y purinoceptor 11 Human genes 0.000 claims description 3
102100026171 P2Y purinoceptor 12 Human genes 0.000 claims description 3
101710192338 P2Y purinoceptor 12 Proteins 0.000 claims description 3
102100028045 P2Y purinoceptor 2 Human genes 0.000 claims description 3
101710096700 P2Y purinoceptor 2 Proteins 0.000 claims description 3
102100028070 P2Y purinoceptor 4 Human genes 0.000 claims description 3
108050009478 P2Y purinoceptor 4 Proteins 0.000 claims description 3
102100028074 P2Y purinoceptor 6 Human genes 0.000 claims description 3
101710096702 P2Y purinoceptor 6 Proteins 0.000 claims description 3
108010016731 PPAR gamma Proteins 0.000 claims description 3
206010061902 Pancreatic neoplasm Diseases 0.000 claims description 3
102100038831 Peroxisome proliferator-activated receptor alpha Human genes 0.000 claims description 3
102100038824 Peroxisome proliferator-activated receptor delta Human genes 0.000 claims description 3
102100038825 Peroxisome proliferator-activated receptor gamma Human genes 0.000 claims description 3
108010064032 Pituitary Adenylate Cyclase-Activating Polypeptide Receptors Proteins 0.000 claims description 3
102000014743 Pituitary Adenylate Cyclase-Activating Polypeptide Receptors Human genes 0.000 claims description 3
108010069381 Platelet Endothelial Cell Adhesion Molecule-1 Proteins 0.000 claims description 3
102000037602 Platelet Endothelial Cell Adhesion Molecule-1 Human genes 0.000 claims description 3
102000002020 Protease-activated receptors Human genes 0.000 claims description 3
108050009310 Protease-activated receptors Proteins 0.000 claims description 3
102100037136 Proteinase-activated receptor 1 Human genes 0.000 claims description 3
102100037132 Proteinase-activated receptor 2 Human genes 0.000 claims description 3
102100037133 Proteinase-activated receptor 3 Human genes 0.000 claims description 3
102100023710 Proteinase-activated receptor 4 Human genes 0.000 claims description 3
102000002298 Purinergic P2Y Receptors Human genes 0.000 claims description 3
108010000818 Purinergic P2Y Receptors Proteins 0.000 claims description 3
206010038389 Renal cancer Diseases 0.000 claims description 3
101000948733 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) Probable phospholipid translocase non-catalytic subunit CRF1 Proteins 0.000 claims description 3
208000000453 Skin Neoplasms Diseases 0.000 claims description 3
102100029329 Somatostatin receptor type 1 Human genes 0.000 claims description 3
102100023803 Somatostatin receptor type 3 Human genes 0.000 claims description 3
102100023801 Somatostatin receptor type 4 Human genes 0.000 claims description 3
102100023806 Somatostatin receptor type 5 Human genes 0.000 claims description 3
208000005718 Stomach Neoplasms Diseases 0.000 claims description 3
101710172711 Structural protein Proteins 0.000 claims description 3
108010002687 Survivin Proteins 0.000 claims description 3
108010072901 Tachykinin Receptors Proteins 0.000 claims description 3
102000007124 Tachykinin Receptors Human genes 0.000 claims description 3
208000024313 Testicular Neoplasms Diseases 0.000 claims description 3
206010057644 Testis cancer Diseases 0.000 claims description 3
102000004852 Thyrotropin-releasing hormone receptors Human genes 0.000 claims description 3
108090001094 Thyrotropin-releasing hormone receptors Proteins 0.000 claims description 3
208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims description 3
102000012327 Urotensin II receptors Human genes 0.000 claims description 3
108050002984 Urotensin II receptors Proteins 0.000 claims description 3
208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims description 3
208000002495 Uterine Neoplasms Diseases 0.000 claims description 3
241000700618 Vaccinia virus Species 0.000 claims description 3
102100038388 Vasoactive intestinal polypeptide receptor 1 Human genes 0.000 claims description 3
101710137655 Vasoactive intestinal polypeptide receptor 1 Proteins 0.000 claims description 3
102100038286 Vasoactive intestinal polypeptide receptor 2 Human genes 0.000 claims description 3
102000004136 Vasopressin Receptors Human genes 0.000 claims description 3
108090000643 Vasopressin Receptors Proteins 0.000 claims description 3
102000034337 acetylcholine receptors Human genes 0.000 claims description 3
108010063640 adrenomedullin receptors Proteins 0.000 claims description 3
SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 claims description 3
108010050122 alpha 1-Antitrypsin Proteins 0.000 claims description 3
102000015395 alpha 1-Antitrypsin Human genes 0.000 claims description 3
229940024142 alpha 1-antitrypsin Drugs 0.000 claims description 3
230000002457 bidirectional effect Effects 0.000 claims description 3
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 3
201000010881 cervical cancer Diseases 0.000 claims description 3
230000000973 chemotherapeutic effect Effects 0.000 claims description 3
208000029742 colonic neoplasm Diseases 0.000 claims description 3
241001493065 dsRNA viruses Species 0.000 claims description 3
201000010063 epididymitis Diseases 0.000 claims description 3
201000004101 esophageal cancer Diseases 0.000 claims description 3
108010038853 gamma-Globins Proteins 0.000 claims description 3
206010017758 gastric cancer Diseases 0.000 claims description 3
201000010536 head and neck cancer Diseases 0.000 claims description 3
208000014829 head and neck neoplasm Diseases 0.000 claims description 3
102000054584 human Y acceptor Human genes 0.000 claims description 3
108700023876 human Y acceptor Proteins 0.000 claims description 3
230000000968 intestinal effect Effects 0.000 claims description 3
201000010982 kidney cancer Diseases 0.000 claims description 3
102000003835 leukotriene receptors Human genes 0.000 claims description 3
108090000146 leukotriene receptors Proteins 0.000 claims description 3
201000007270 liver cancer Diseases 0.000 claims description 3
208000014018 liver neoplasm Diseases 0.000 claims description 3
230000001926 lymphatic effect Effects 0.000 claims description 3
208000015486 malignant pancreatic neoplasm Diseases 0.000 claims description 3
229940005483 opioid analgesics Drugs 0.000 claims description 3
201000002528 pancreatic cancer Diseases 0.000 claims description 3
230000003076 paracrine Effects 0.000 claims description 3
239000003614 peroxisome proliferator Substances 0.000 claims description 3
108091008725 peroxisome proliferator-activated receptors alpha Proteins 0.000 claims description 3
108091008765 peroxisome proliferator-activated receptors β/δ Proteins 0.000 claims description 3
108010042121 probasin Proteins 0.000 claims description 3
210000001236 prokaryotic cell Anatomy 0.000 claims description 3
102000017953 prostanoid receptors Human genes 0.000 claims description 3
108050007059 prostanoid receptors Proteins 0.000 claims description 3
230000003439 radiotherapeutic effect Effects 0.000 claims description 3
229930002330 retinoic acid Natural products 0.000 claims description 3
201000000849 skin cancer Diseases 0.000 claims description 3
108010064556 somatostatin receptor subtype-4 Proteins 0.000 claims description 3
108010082379 somatostatin receptor type 1 Proteins 0.000 claims description 3
201000011549 stomach cancer Diseases 0.000 claims description 3
108010057210 telomerase RNA Proteins 0.000 claims description 3
201000003120 testicular cancer Diseases 0.000 claims description 3
229960001727 tretinoin Drugs 0.000 claims description 3
201000005112 urinary bladder cancer Diseases 0.000 claims description 3
206010046766 uterine cancer Diseases 0.000 claims description 3
YQNRVGJCPCNMKT-JLPGSUDCSA-N 2-(4-benzylpiperazin-1-yl)-n-[(2-hydroxy-3-prop-2-enyl-phenyl)methylideneamino]acetamide Chemical compound OC1=C(CC=C)C=CC=C1\C=N/NC(=O)CN1CCN(CC=2C=CC=CC=2)CC1 YQNRVGJCPCNMKT-JLPGSUDCSA-N 0.000 claims description 2
102100026189 Beta-galactosidase Human genes 0.000 claims description 2
108010073466 Bombesin Receptors Proteins 0.000 claims description 2
102100031172 C-C chemokine receptor type 1 Human genes 0.000 claims description 2
101710149814 C-C chemokine receptor type 1 Proteins 0.000 claims description 2
102100036166 C-X-C chemokine receptor type 1 Human genes 0.000 claims description 2
108090000835 CX3C Chemokine Receptor 1 Proteins 0.000 claims description 2
102100039196 CX3C chemokine receptor 1 Human genes 0.000 claims description 2
102000018208 Cannabinoid Receptor Human genes 0.000 claims description 2
108050007331 Cannabinoid receptor Proteins 0.000 claims description 2
102100035294 Chemokine XC receptor 1 Human genes 0.000 claims description 2
102000005289 Eukaryotic Initiation Factor-4A Human genes 0.000 claims description 2
108010056472 Eukaryotic Initiation Factor-4A Proteins 0.000 claims description 2
101150094690 GAL1 gene Proteins 0.000 claims description 2
108010027992 HSP70 Heat-Shock Proteins Proteins 0.000 claims description 2
102000018932 HSP70 Heat-Shock Proteins Human genes 0.000 claims description 2
101710113864 Heat shock protein 90 Proteins 0.000 claims description 2
101000947174 Homo sapiens C-X-C chemokine receptor type 1 Proteins 0.000 claims description 2
101000804783 Homo sapiens Chemokine XC receptor 1 Proteins 0.000 claims description 2
101100121078 Homo sapiens GAL gene Proteins 0.000 claims description 2
101001139126 Homo sapiens Krueppel-like factor 6 Proteins 0.000 claims description 2
101001133600 Homo sapiens Pituitary adenylate cyclase-activating polypeptide type I receptor Proteins 0.000 claims description 2
101000772905 Homo sapiens Polyubiquitin-B Proteins 0.000 claims description 2
101001080401 Homo sapiens Proteasome assembly chaperone 1 Proteins 0.000 claims description 2
101000693265 Homo sapiens Sphingosine 1-phosphate receptor 1 Proteins 0.000 claims description 2
102100020679 Krueppel-like factor 6 Human genes 0.000 claims description 2
241000713666 Lentivirus Species 0.000 claims description 2
229960005552 PAC-1 Drugs 0.000 claims description 2
102000010292 Peptide Elongation Factor 1 Human genes 0.000 claims description 2
108010077524 Peptide Elongation Factor 1 Proteins 0.000 claims description 2
102000011755 Phosphoglycerate Kinase Human genes 0.000 claims description 2
108010039918 Polylysine Proteins 0.000 claims description 2
102100030432 Polyubiquitin-B Human genes 0.000 claims description 2
241000125945 Protoparvovirus Species 0.000 claims description 2
102100025750 Sphingosine 1-phosphate receptor 1 Human genes 0.000 claims description 2
101001099217 Thermotoga maritima (strain ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8) Triosephosphate isomerase Proteins 0.000 claims description 2
102400000757 Ubiquitin Human genes 0.000 claims description 2
108090000848 Ubiquitin Proteins 0.000 claims description 2
108010005774 beta-Galactosidase Proteins 0.000 claims description 2
230000003399 chemotactic effect Effects 0.000 claims description 2
230000002255 enzymatic effect Effects 0.000 claims description 2
230000005294 ferromagnetic effect Effects 0.000 claims description 2
108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 claims description 2
102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 claims description 2
230000004068 intracellular signaling Effects 0.000 claims description 2
229910052751 metal Inorganic materials 0.000 claims description 2
239000002184 metal Substances 0.000 claims description 2
229920000656 polylysine Polymers 0.000 claims description 2
229940002612 prodrug Drugs 0.000 claims description 2
239000000651 prodrug Substances 0.000 claims description 2
238000002603 single-photon emission computed tomography Methods 0.000 claims description 2
150000003384 small molecules Chemical class 0.000 claims description 2
241001529453 unidentified herpesvirus Species 0.000 claims description 2
102100039564 Leukosialin Human genes 0.000 claims 4
108010005832 Leukosialin Proteins 0.000 claims 4
102100025136 Macrosialin Human genes 0.000 claims 4
101710156482 Macrosialin Proteins 0.000 claims 4
102000003909 Cyclin E Human genes 0.000 claims 2
108090000257 Cyclin E Proteins 0.000 claims 2
102100036912 Desmin Human genes 0.000 claims 2
108010044052 Desmin Proteins 0.000 claims 2
102000015699 E2F1 Transcription Factor Human genes 0.000 claims 2
108010036395 Endoglin Proteins 0.000 claims 2
102100037241 Endoglin Human genes 0.000 claims 2
108010067306 Fibronectins Proteins 0.000 claims 2
102000016359 Fibronectins Human genes 0.000 claims 2
102000053171 Glial Fibrillary Acidic Human genes 0.000 claims 2
101710193519 Glial fibrillary acidic protein Proteins 0.000 claims 2
102100041003 Glutamate carboxypeptidase 2 Human genes 0.000 claims 2
102100029242 Hexokinase-2 Human genes 0.000 claims 2
101710198385 Hexokinase-2 Proteins 0.000 claims 2
101000892862 Homo sapiens Glutamate carboxypeptidase 2 Proteins 0.000 claims 2
101000998011 Homo sapiens Keratin, type I cytoskeletal 19 Proteins 0.000 claims 2
101000685275 Homo sapiens Protein sel-1 homolog 1 Proteins 0.000 claims 2
101001086862 Homo sapiens Pulmonary surfactant-associated protein B Proteins 0.000 claims 2
102100037872 Intercellular adhesion molecule 2 Human genes 0.000 claims 2
101710148794 Intercellular adhesion molecule 2 Proteins 0.000 claims 2
102100020873 Interleukin-2 Human genes 0.000 claims 2
102100033420 Keratin, type I cytoskeletal 19 Human genes 0.000 claims 2
108010013709 Leukocyte Common Antigens Proteins 0.000 claims 2
108010008699 Mucin-4 Proteins 0.000 claims 2
102100022693 Mucin-4 Human genes 0.000 claims 2
102100030856 Myoglobin Human genes 0.000 claims 2
108010062374 Myoglobin Proteins 0.000 claims 2
101710201287 Osteocalcin 2 Proteins 0.000 claims 2
102100023159 Protein sel-1 homolog 1 Human genes 0.000 claims 2
102100032617 Pulmonary surfactant-associated protein B Human genes 0.000 claims 2
102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 claims 2
102100023802 Somatostatin receptor type 2 Human genes 0.000 claims 2
102000001435 Synapsin Human genes 0.000 claims 2
108050009621 Synapsin Proteins 0.000 claims 2
108010088412 Trefoil Factor-1 Proteins 0.000 claims 2
102100039175 Trefoil factor 1 Human genes 0.000 claims 2
108091008605 VEGF receptors Proteins 0.000 claims 2
102000009484 Vascular Endothelial Growth Factor Receptors Human genes 0.000 claims 2
210000005045 desmin Anatomy 0.000 claims 2
210000005046 glial fibrillary acidic protein Anatomy 0.000 claims 2
229960001388 interferon-beta Drugs 0.000 claims 2
210000001616 monocyte Anatomy 0.000 claims 2
102100037853 C-C chemokine receptor type 4 Human genes 0.000 claims 1
102100038496 Cysteinyl leukotriene receptor 1 Human genes 0.000 claims 1
101000882759 Homo sapiens Cysteinyl leukotriene receptor 1 Proteins 0.000 claims 1
102000004338 Transferrin Human genes 0.000 claims 1
108090000901 Transferrin Proteins 0.000 claims 1
238000012831 peritoneal equilibrium test Methods 0.000 claims 1
238000012636 positron electron tomography Methods 0.000 claims 1
238000012877 positron emission topography Methods 0.000 claims 1
239000012581 transferrin Substances 0.000 claims 1
239000002246 antineoplastic agent Substances 0.000 abstract description 3
125000003275 alpha amino acid group Chemical group 0.000 abstract 1
239000013598 vector Substances 0.000 description 92
230000000694 effects Effects 0.000 description 39
239000003795 chemical substances by application Substances 0.000 description 35
238000001415 gene therapy Methods 0.000 description 32
108020001507 fusion proteins Proteins 0.000 description 30
102000037865 fusion proteins Human genes 0.000 description 30
241000701161 unidentified adenovirus Species 0.000 description 28
229940124269 Somatostatin receptor 2 agonist Drugs 0.000 description 26
108020004684 Internal Ribosome Entry Sites Proteins 0.000 description 25
238000012546 transfer Methods 0.000 description 25
238000002600 positron emission tomography Methods 0.000 description 22
241001465754 Metazoa Species 0.000 description 21
230000009977 dual effect Effects 0.000 description 20
238000000338 in vitro Methods 0.000 description 20
238000002560 therapeutic procedure Methods 0.000 description 20
241000699670 Mus sp. Species 0.000 description 19
108010048367 enhanced green fluorescent protein Proteins 0.000 description 19
102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 17
108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 17
239000012217 radiopharmaceutical Substances 0.000 description 17
229940121896 radiopharmaceutical Drugs 0.000 description 17
230000002799 radiopharmaceutical effect Effects 0.000 description 17
238000013518 transcription Methods 0.000 description 17
230000035897 transcription Effects 0.000 description 17
238000004458 analytical method Methods 0.000 description 16
239000003623 enhancer Substances 0.000 description 16
238000011282 treatment Methods 0.000 description 16
230000008685 targeting Effects 0.000 description 15
241000699666 Mus <mouse, genus> Species 0.000 description 14
238000011161 development Methods 0.000 description 14
230000018109 developmental process Effects 0.000 description 14
230000006870 function Effects 0.000 description 14
238000002347 injection Methods 0.000 description 14
239000007924 injection Substances 0.000 description 14
238000002595 magnetic resonance imaging Methods 0.000 description 14
229940124597 therapeutic agent Drugs 0.000 description 14
108700008625 Reporter Genes Proteins 0.000 description 13
235000001014 amino acid Nutrition 0.000 description 13
230000008901 benefit Effects 0.000 description 13
230000012010 growth Effects 0.000 description 13
239000012216 imaging agent Substances 0.000 description 13
230000001105 regulatory effect Effects 0.000 description 13
108700019146 Transgenes Proteins 0.000 description 12
238000013459 approach Methods 0.000 description 12
230000001965 increasing effect Effects 0.000 description 12
230000003902 lesion Effects 0.000 description 12
239000013604 expression vector Substances 0.000 description 11
239000002105 nanoparticle Substances 0.000 description 11
238000011580 nude mouse model Methods 0.000 description 11
108020004635 Complementary DNA Proteins 0.000 description 10
102000044209 Tumor Suppressor Genes Human genes 0.000 description 10
108700025716 Tumor Suppressor Genes Proteins 0.000 description 10
239000002585 base Substances 0.000 description 10
238000005516 engineering process Methods 0.000 description 10
208000015181 infectious disease Diseases 0.000 description 10
230000001404 mediated effect Effects 0.000 description 10
229960002700 octreotide Drugs 0.000 description 10
230000008488 polyadenylation Effects 0.000 description 10
230000010076 replication Effects 0.000 description 10
NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 description 10
231100000419 toxicity Toxicity 0.000 description 10
230000001988 toxicity Effects 0.000 description 10
238000011144 upstream manufacturing Methods 0.000 description 10
108091034117 Oligonucleotide Proteins 0.000 description 9
241000700584 Simplexvirus Species 0.000 description 9
108010056088 Somatostatin Proteins 0.000 description 9
102000005157 Somatostatin Human genes 0.000 description 9
239000000427 antigen Substances 0.000 description 9
108091007433 antigens Proteins 0.000 description 9
102000036639 antigens Human genes 0.000 description 9
238000010804 cDNA synthesis Methods 0.000 description 9
239000002299 complementary DNA Substances 0.000 description 9
150000001875 compounds Chemical class 0.000 description 9
239000002872 contrast media Substances 0.000 description 9
206010012601 diabetes mellitus Diseases 0.000 description 9
230000004807 localization Effects 0.000 description 9
239000012528 membrane Substances 0.000 description 9
239000000047 product Substances 0.000 description 9
239000000523 sample Substances 0.000 description 9
229960000553 somatostatin Drugs 0.000 description 9
238000001262 western blot Methods 0.000 description 9
238000001514 detection method Methods 0.000 description 8
230000003463 hyperproliferative effect Effects 0.000 description 8
230000005764 inhibitory process Effects 0.000 description 8
238000012544 monitoring process Methods 0.000 description 8
102000040430 polynucleotide Human genes 0.000 description 8
108091033319 polynucleotide Proteins 0.000 description 8
239000002157 polynucleotide Substances 0.000 description 8
102000004127 Cytokines Human genes 0.000 description 7
108090000695 Cytokines Proteins 0.000 description 7
108700028146 Genetic Enhancer Elements Proteins 0.000 description 7
102000048850 Neoplasm Genes Human genes 0.000 description 7
108700019961 Neoplasm Genes Proteins 0.000 description 7
102100033254 Tumor suppressor ARF Human genes 0.000 description 7
238000003556 assay Methods 0.000 description 7
238000002474 experimental method Methods 0.000 description 7
239000012634 fragment Substances 0.000 description 7
230000002068 genetic effect Effects 0.000 description 7
108700040425 indium-111-octreotide Proteins 0.000 description 7
238000002955 isolation Methods 0.000 description 7
239000007788 liquid Substances 0.000 description 7
238000004519 manufacturing process Methods 0.000 description 7
229910021645 metal ion Inorganic materials 0.000 description 7
210000000056 organ Anatomy 0.000 description 7
239000000700 radioactive tracer Substances 0.000 description 7
238000001959 radiotherapy Methods 0.000 description 7
239000000243 solution Substances 0.000 description 7
238000007920 subcutaneous administration Methods 0.000 description 7
238000013519 translation Methods 0.000 description 7
DEQANNDTNATYII-OULOTJBUSA-N (4r,7s,10s,13r,16s,19r)-10-(4-aminobutyl)-19-[[(2r)-2-amino-3-phenylpropanoyl]amino]-16-benzyl-n-[(2r,3r)-1,3-dihydroxybutan-2-yl]-7-[(1r)-1-hydroxyethyl]-13-(1h-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxa Chemical compound C([C@@H](N)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC=2C3=CC=CC=C3NC=2)NC(=O)[C@H](CC=2C=CC=CC=2)NC1=O)C(=O)N[C@H](CO)[C@H](O)C)C1=CC=CC=C1 DEQANNDTNATYII-OULOTJBUSA-N 0.000 description 6
108010022366 Carcinoembryonic Antigen Proteins 0.000 description 6
102000012673 Follicle Stimulating Hormone Human genes 0.000 description 6
108010079345 Follicle Stimulating Hormone Proteins 0.000 description 6
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 6
108010016076 Octreotide Proteins 0.000 description 6
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
210000001744 T-lymphocyte Anatomy 0.000 description 6
210000000170 cell membrane Anatomy 0.000 description 6
239000003153 chemical reaction reagent Substances 0.000 description 6
238000003745 diagnosis Methods 0.000 description 6
229940028334 follicle stimulating hormone Drugs 0.000 description 6
238000001476 gene delivery Methods 0.000 description 6
238000009169 immunotherapy Methods 0.000 description 6
230000002401 inhibitory effect Effects 0.000 description 6
230000003834 intracellular effect Effects 0.000 description 6
239000002773 nucleotide Substances 0.000 description 6
125000003729 nucleotide group Chemical group 0.000 description 6
238000011275 oncology therapy Methods 0.000 description 6
238000002360 preparation method Methods 0.000 description 6
230000002265 prevention Effects 0.000 description 6
102000004506 Blood Proteins Human genes 0.000 description 5
108010017384 Blood Proteins Proteins 0.000 description 5
101100064718 Borrelia bavariensis (strain ATCC BAA-2496 / DSM 23469 / PBi) fusA1 gene Proteins 0.000 description 5
101100209555 Caenorhabditis elegans vha-17 gene Proteins 0.000 description 5
108020004705 Codon Proteins 0.000 description 5
201000008808 Fibrosarcoma Diseases 0.000 description 5
241000282412 Homo Species 0.000 description 5
241000699660 Mus musculus Species 0.000 description 5
102000014160 PTEN Phosphohydrolase Human genes 0.000 description 5
108010011536 PTEN Phosphohydrolase Proteins 0.000 description 5
102000011923 Thyrotropin Human genes 0.000 description 5
108010061174 Thyrotropin Proteins 0.000 description 5
238000002512 chemotherapy Methods 0.000 description 5
239000012636 effector Substances 0.000 description 5
239000000284 extract Substances 0.000 description 5
230000010354 integration Effects 0.000 description 5
229910052740 iodine Inorganic materials 0.000 description 5
230000036210 malignancy Effects 0.000 description 5
210000004962 mammalian cell Anatomy 0.000 description 5
230000000861 pro-apoptotic effect Effects 0.000 description 5
230000008569 process Effects 0.000 description 5
230000005855 radiation Effects 0.000 description 5
210000000130 stem cell Anatomy 0.000 description 5
230000009885 systemic effect Effects 0.000 description 5
230000002103 transcriptional effect Effects 0.000 description 5
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 5
210000000689 upper leg Anatomy 0.000 description 5
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
102100025064 Cellular tumor antigen p53 Human genes 0.000 description 4
108091005941 EBFP Proteins 0.000 description 4
206010014611 Encephalitis venezuelan equine Diseases 0.000 description 4
108010050904 Interferons Proteins 0.000 description 4
102000014150 Interferons Human genes 0.000 description 4
108010065805 Interleukin-12 Proteins 0.000 description 4
102000000588 Interleukin-2 Human genes 0.000 description 4
108091000080 Phosphotransferase Proteins 0.000 description 4
102100021657 Tyrosine-protein phosphatase non-receptor type 6 Human genes 0.000 description 4
101710128901 Tyrosine-protein phosphatase non-receptor type 6 Proteins 0.000 description 4
230000009471 action Effects 0.000 description 4
239000004480 active ingredient Substances 0.000 description 4
230000008499 blood brain barrier function Effects 0.000 description 4
210000001218 blood-brain barrier Anatomy 0.000 description 4
230000037396 body weight Effects 0.000 description 4
230000001413 cellular effect Effects 0.000 description 4
230000008859 change Effects 0.000 description 4
238000006243 chemical reaction Methods 0.000 description 4
210000000349 chromosome Anatomy 0.000 description 4
238000002648 combination therapy Methods 0.000 description 4
230000000875 corresponding effect Effects 0.000 description 4
230000003247 decreasing effect Effects 0.000 description 4
238000009826 distribution Methods 0.000 description 4
108010045262 enhanced cyan fluorescent protein Proteins 0.000 description 4
VJJPUSNTGOMMGY-MRVIYFEKSA-N etoposide Chemical compound COC1=C(O)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H]4O[C@H](C)OC[C@H]4O3)O)[C@@H]3[C@@H]2C(OC3)=O)=C1 VJJPUSNTGOMMGY-MRVIYFEKSA-N 0.000 description 4
238000009472 formulation Methods 0.000 description 4
239000003966 growth inhibitor Substances 0.000 description 4
UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 4
229940121354 immunomodulator Drugs 0.000 description 4
229940079322 interferon Drugs 0.000 description 4
239000000463 material Substances 0.000 description 4
238000005259 measurement Methods 0.000 description 4
108020004999 messenger RNA Proteins 0.000 description 4
102000020233 phosphotransferase Human genes 0.000 description 4
230000035755 proliferation Effects 0.000 description 4
102000016914 ras Proteins Human genes 0.000 description 4
108010014186 ras Proteins Proteins 0.000 description 4
230000001177 retroviral effect Effects 0.000 description 4
150000003839 salts Chemical class 0.000 description 4
239000002904 solvent Substances 0.000 description 4
102000055501 telomere Human genes 0.000 description 4
108091035539 telomere Proteins 0.000 description 4
210000003411 telomere Anatomy 0.000 description 4
238000001890 transfection Methods 0.000 description 4
230000032258 transport Effects 0.000 description 4
238000012285 ultrasound imaging Methods 0.000 description 4
KSXTUUUQYQYKCR-LQDDAWAPSA-M 2,3-bis[[(z)-octadec-9-enoyl]oxy]propyl-trimethylazanium;chloride Chemical compound [Cl-].CCCCCCCC\C=C/CCCCCCCC(=O)OCC(C[N+](C)(C)C)OC(=O)CCCCCCC\C=C/CCCCCCCC KSXTUUUQYQYKCR-LQDDAWAPSA-M 0.000 description 3
102100034540 Adenomatous polyposis coli protein Human genes 0.000 description 3
108700020462 BRCA2 Proteins 0.000 description 3
102000052609 BRCA2 Human genes 0.000 description 3
101150008921 Brca2 gene Proteins 0.000 description 3
108010062802 CD66 antigens Proteins 0.000 description 3
102000053642 Catalytic RNA Human genes 0.000 description 3
108090000994 Catalytic RNA Proteins 0.000 description 3
102100028233 Coronin-1A Human genes 0.000 description 3
102000053602 DNA Human genes 0.000 description 3
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
102000003951 Erythropoietin Human genes 0.000 description 3
108090000394 Erythropoietin Proteins 0.000 description 3
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
108700039691 Genetic Promoter Regions Proteins 0.000 description 3
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 3
HVLSXIKZNLPZJJ-TXZCQADKSA-N HA peptide Chemical compound C([C@@H](C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 HVLSXIKZNLPZJJ-TXZCQADKSA-N 0.000 description 3
101000924577 Homo sapiens Adenomatous polyposis coli protein Proteins 0.000 description 3
101000721661 Homo sapiens Cellular tumor antigen p53 Proteins 0.000 description 3
241000701044 Human gammaherpesvirus 4 Species 0.000 description 3
102100034349 Integrase Human genes 0.000 description 3
102000015696 Interleukins Human genes 0.000 description 3
108010063738 Interleukins Proteins 0.000 description 3
108091092195 Intron Proteins 0.000 description 3
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 3
108700026244 Open Reading Frames Proteins 0.000 description 3
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
108700026226 TATA Box Proteins 0.000 description 3
108010091356 Tumor Protein p73 Proteins 0.000 description 3
102000018252 Tumor Protein p73 Human genes 0.000 description 3
208000002687 Venezuelan Equine Encephalomyelitis Diseases 0.000 description 3
201000009145 Venezuelan equine encephalitis Diseases 0.000 description 3
108010067390 Viral Proteins Proteins 0.000 description 3
238000010521 absorption reaction Methods 0.000 description 3
230000004075 alteration Effects 0.000 description 3
210000002588 alveolar type II cell Anatomy 0.000 description 3
229940124650 anti-cancer therapies Drugs 0.000 description 3
230000009286 beneficial effect Effects 0.000 description 3
238000001574 biopsy Methods 0.000 description 3
108010006025 bovine growth hormone Proteins 0.000 description 3
230000003491 cAMP production Effects 0.000 description 3
239000000969 carrier Substances 0.000 description 3
125000002091 cationic group Chemical group 0.000 description 3
238000002659 cell therapy Methods 0.000 description 3
230000004087 circulation Effects 0.000 description 3
RAURUSFBVQLAPW-DNIKMYEQSA-N clocinnamox Chemical compound N1([C@@H]2CC3=CC=C(C=4O[C@@H]5[C@](C3=4)([C@]2(CCC5=O)NC(=O)\C=C\C=2C=CC(Cl)=CC=2)CC1)O)CC1CC1 RAURUSFBVQLAPW-DNIKMYEQSA-N 0.000 description 3
238000010367 cloning Methods 0.000 description 3
230000000295 complement effect Effects 0.000 description 3
238000010276 construction Methods 0.000 description 3
238000011498 curative surgery Methods 0.000 description 3
230000001086 cytosolic effect Effects 0.000 description 3
230000001419 dependent effect Effects 0.000 description 3
238000010790 dilution Methods 0.000 description 3
239000012895 dilution Substances 0.000 description 3
239000002612 dispersion medium Substances 0.000 description 3
229940105423 erythropoietin Drugs 0.000 description 3
238000011156 evaluation Methods 0.000 description 3
210000002950 fibroblast Anatomy 0.000 description 3
239000012530 fluid Substances 0.000 description 3
210000003958 hematopoietic stem cell Anatomy 0.000 description 3
239000012642 immune effector Substances 0.000 description 3
230000028993 immune response Effects 0.000 description 3
238000010166 immunofluorescence Methods 0.000 description 3
230000001976 improved effect Effects 0.000 description 3
238000011065 in-situ storage Methods 0.000 description 3
230000006698 induction Effects 0.000 description 3
230000006882 induction of apoptosis Effects 0.000 description 3
230000001939 inductive effect Effects 0.000 description 3
239000004615 ingredient Substances 0.000 description 3
230000003993 interaction Effects 0.000 description 3
108090000237 interleukin-24 Proteins 0.000 description 3
102000003898 interleukin-24 Human genes 0.000 description 3
238000010253 intravenous injection Methods 0.000 description 3
150000002500 ions Chemical class 0.000 description 3
230000004048 modification Effects 0.000 description 3
238000012986 modification Methods 0.000 description 3
239000013642 negative control Substances 0.000 description 3
239000002245 particle Substances 0.000 description 3
230000001575 pathological effect Effects 0.000 description 3
239000002953 phosphate buffered saline Substances 0.000 description 3
239000013600 plasmid vector Substances 0.000 description 3
OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 3
239000003755 preservative agent Substances 0.000 description 3
238000011002 quantification Methods 0.000 description 3
238000001525 receptor binding assay Methods 0.000 description 3
238000002271 resection Methods 0.000 description 3
108091092562 ribozyme Proteins 0.000 description 3
230000028327 secretion Effects 0.000 description 3
239000011780 sodium chloride Substances 0.000 description 3
210000004872 soft tissue Anatomy 0.000 description 3
241000894007 species Species 0.000 description 3
238000010186 staining Methods 0.000 description 3
230000004960 subcellular localization Effects 0.000 description 3
239000004094 surface-active agent Substances 0.000 description 3
230000002123 temporal effect Effects 0.000 description 3
238000003325 tomography Methods 0.000 description 3
230000004614 tumor growth Effects 0.000 description 3
230000002792 vascular Effects 0.000 description 3
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
VGIRNWJSIRVFRT-UHFFFAOYSA-N 2',7'-difluorofluorescein Chemical compound OC(=O)C1=CC=CC=C1C1=C2C=C(F)C(=O)C=C2OC2=CC(O)=C(F)C=C21 VGIRNWJSIRVFRT-UHFFFAOYSA-N 0.000 description 2
102000036365 BRCA1 Human genes 0.000 description 2
108700020463 BRCA1 Proteins 0.000 description 2
101150072950 BRCA1 gene Proteins 0.000 description 2
206010061728 Bone lesion Diseases 0.000 description 2
108091003079 Bovine Serum Albumin Proteins 0.000 description 2
102100032976 CCR4-NOT transcription complex subunit 6 Human genes 0.000 description 2
101150110592 CTS1 gene Proteins 0.000 description 2
108090000489 Carboxy-Lyases Proteins 0.000 description 2
102100021809 Chorionic somatomammotropin hormone 1 Human genes 0.000 description 2
108091005960 Citrine Proteins 0.000 description 2
108700010070 Codon Usage Proteins 0.000 description 2
102000007644 Colony-Stimulating Factors Human genes 0.000 description 2
108010071942 Colony-Stimulating Factors Proteins 0.000 description 2
102000012437 Copper-Transporting ATPases Human genes 0.000 description 2
108010022637 Copper-Transporting ATPases Proteins 0.000 description 2
108010009392 Cyclin-Dependent Kinase Inhibitor p16 Proteins 0.000 description 2
108010079245 Cystic Fibrosis Transmembrane Conductance Regulator Proteins 0.000 description 2
102000000311 Cytosine Deaminase Human genes 0.000 description 2
108010080611 Cytosine Deaminase Proteins 0.000 description 2
108090000626 DNA-directed RNA polymerases Proteins 0.000 description 2
102000004163 DNA-directed RNA polymerases Human genes 0.000 description 2
241000006867 Discosoma Species 0.000 description 2
AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 2
206010059866 Drug resistance Diseases 0.000 description 2
239000006144 Dulbecco’s modiﬁed Eagle's medium Substances 0.000 description 2
YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 2
102100029951 Estrogen receptor beta Human genes 0.000 description 2
238000012413 Fluorescence activated cell sorting analysis Methods 0.000 description 2
241000027294 Fusi Species 0.000 description 2
229910052688 Gadolinium Inorganic materials 0.000 description 2
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
101710154606 Hemagglutinin Proteins 0.000 description 2
NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
101000899339 Homo sapiens Lymphoid-specific helicase Proteins 0.000 description 2
101000995705 Homo sapiens Natural resistance-associated macrophage protein 1 Proteins 0.000 description 2
101150003028 Hprt1 gene Proteins 0.000 description 2
241001135569 Human adenovirus 5 Species 0.000 description 2
241000700588 Human alphaherpesvirus 1 Species 0.000 description 2
108010091358 Hypoxanthine Phosphoribosyltransferase Proteins 0.000 description 2
102100029098 Hypoxanthine-guanine phosphoribosyltransferase Human genes 0.000 description 2
208000026350 Inborn Genetic disease Diseases 0.000 description 2
102100037852 Insulin-like growth factor I Human genes 0.000 description 2
108010002352 Interleukin-1 Proteins 0.000 description 2
102000000589 Interleukin-1 Human genes 0.000 description 2
108090000174 Interleukin-10 Proteins 0.000 description 2
102000003814 Interleukin-10 Human genes 0.000 description 2
108090000177 Interleukin-11 Proteins 0.000 description 2
102000003815 Interleukin-11 Human genes 0.000 description 2
108010002386 Interleukin-3 Proteins 0.000 description 2
108090000978 Interleukin-4 Proteins 0.000 description 2
108010002616 Interleukin-5 Proteins 0.000 description 2
108090001005 Interleukin-6 Proteins 0.000 description 2
108010002586 Interleukin-7 Proteins 0.000 description 2
108090001007 Interleukin-8 Proteins 0.000 description 2
108010002335 Interleukin-9 Proteins 0.000 description 2
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
238000012313 Kruskal-Wallis test Methods 0.000 description 2
DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
102000016267 Leptin Human genes 0.000 description 2
108010092277 Leptin Proteins 0.000 description 2
102000003960 Ligases Human genes 0.000 description 2
108090000364 Ligases Proteins 0.000 description 2
102000009151 Luteinizing Hormone Human genes 0.000 description 2
108010073521 Luteinizing Hormone Proteins 0.000 description 2
102000004317 Lyases Human genes 0.000 description 2
108090000856 Lyases Proteins 0.000 description 2
102100022539 Lymphoid-specific helicase Human genes 0.000 description 2
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
239000002616 MRI contrast agent Substances 0.000 description 2
101150114843 Mgll gene Proteins 0.000 description 2
102100025751 Mothers against decapentaplegic homolog 2 Human genes 0.000 description 2
102100025725 Mothers against decapentaplegic homolog 4 Human genes 0.000 description 2
206010073148 Multiple endocrine neoplasia type 2A Diseases 0.000 description 2
102100038895 Myc proto-oncogene protein Human genes 0.000 description 2
UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
108010025020 Nerve Growth Factor Proteins 0.000 description 2
208000012902 Nervous system disease Diseases 0.000 description 2
102000006538 Nitric Oxide Synthase Type I Human genes 0.000 description 2
108010008858 Nitric Oxide Synthase Type I Proteins 0.000 description 2
101710093908 Outer capsid protein VP4 Proteins 0.000 description 2
101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 2
238000012879 PET imaging Methods 0.000 description 2
102000043299 Parathyroid hormone-related Human genes 0.000 description 2
101710123753 Parathyroid hormone-related protein Proteins 0.000 description 2
102000035195 Peptidases Human genes 0.000 description 2
108091005804 Peptidases Proteins 0.000 description 2
108010081690 Pertussis Toxin Proteins 0.000 description 2
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
108010069013 Phenylalanine Hydroxylase Proteins 0.000 description 2
102100038223 Phenylalanine-4-hydroxylase Human genes 0.000 description 2
102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 2
108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 2
102000009097 Phosphorylases Human genes 0.000 description 2
108010073135 Phosphorylases Proteins 0.000 description 2
108010003044 Placental Lactogen Proteins 0.000 description 2
239000000381 Placental Lactogen Substances 0.000 description 2
102000003946 Prolactin Human genes 0.000 description 2
108010057464 Prolactin Proteins 0.000 description 2
101710176177 Protein A56 Proteins 0.000 description 2
102100028588 Protein ZNRD2 Human genes 0.000 description 2
101100534342 Rattus norvegicus Sstr2 gene Proteins 0.000 description 2
241000242743 Renilla reniformis Species 0.000 description 2
240000004808 Saccharomyces cerevisiae Species 0.000 description 2
108700032504 Smad2 Proteins 0.000 description 2
101150102611 Smad2 gene Proteins 0.000 description 2
PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
102100020886 Sodium/iodide cotransporter Human genes 0.000 description 2
108090000088 Symporters Proteins 0.000 description 2
102000003673 Symporters Human genes 0.000 description 2
NKANXQFJJICGDU-QPLCGJKRSA-N Tamoxifen Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 NKANXQFJJICGDU-QPLCGJKRSA-N 0.000 description 2
102000036693 Thrombopoietin Human genes 0.000 description 2
108010041111 Thrombopoietin Proteins 0.000 description 2
IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
108700009124 Transcription Initiation Site Proteins 0.000 description 2
102100040250 Transcription elongation factor A protein-like 1 Human genes 0.000 description 2
108010009583 Transforming Growth Factors Proteins 0.000 description 2
102000009618 Transforming Growth Factors Human genes 0.000 description 2
102100033019 Tyrosine-protein phosphatase non-receptor type 11 Human genes 0.000 description 2
101710116241 Tyrosine-protein phosphatase non-receptor type 11 Proteins 0.000 description 2
ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 2
108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 2
108700005077 Viral Genes Proteins 0.000 description 2
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
RJURFGZVJUQBHK-UHFFFAOYSA-N actinomycin D Natural products CC1OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C2CCCN2C(=O)C(C(C)C)NC(=O)C1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)NC4C(=O)NC(C(N5CCCC5C(=O)N(C)CC(=O)N(C)C(C(C)C)C(=O)OC4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-UHFFFAOYSA-N 0.000 description 2
230000004913 activation Effects 0.000 description 2
OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
230000002411 adverse Effects 0.000 description 2
238000002583 angiography Methods 0.000 description 2
239000003242 anti bacterial agent Substances 0.000 description 2
229940121375 antifungal agent Drugs 0.000 description 2
239000003429 antifungal agent Substances 0.000 description 2
239000003963 antioxidant agent Substances 0.000 description 2
239000012736 aqueous medium Substances 0.000 description 2
102000055102 bcl-2-Associated X Human genes 0.000 description 2
108700000707 bcl-2-Associated X Proteins 0.000 description 2
239000011230 binding agent Substances 0.000 description 2
230000004071 biological effect Effects 0.000 description 2
229960002685 biotin Drugs 0.000 description 2
235000020958 biotin Nutrition 0.000 description 2
239000011616 biotin Substances 0.000 description 2
210000004369 blood Anatomy 0.000 description 2
239000008280 blood Substances 0.000 description 2
230000017531 blood circulation Effects 0.000 description 2
210000004204 blood vessel Anatomy 0.000 description 2
230000022534 cell killing Effects 0.000 description 2
230000003833 cell viability Effects 0.000 description 2
238000005119 centrifugation Methods 0.000 description 2
238000012512 characterization method Methods 0.000 description 2
OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 2
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
239000011035 citrine Substances 0.000 description 2
238000003776 cleavage reaction Methods 0.000 description 2
230000008045 co-localization Effects 0.000 description 2
238000000576 coating method Methods 0.000 description 2
229940047120 colony stimulating factors Drugs 0.000 description 2
238000002591 computed tomography Methods 0.000 description 2
230000002596 correlated effect Effects 0.000 description 2
230000009089 cytolysis Effects 0.000 description 2
OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
208000035475 disorder Diseases 0.000 description 2
239000006185 dispersion Substances 0.000 description 2
VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
239000000975 dye Substances 0.000 description 2
210000003981 ectoderm Anatomy 0.000 description 2
238000005538 encapsulation Methods 0.000 description 2
210000001900 endoderm Anatomy 0.000 description 2
102000015694 estrogen receptors Human genes 0.000 description 2
108010038795 estrogen receptors Proteins 0.000 description 2
239000013613 expression plasmid Substances 0.000 description 2
230000002349 favourable effect Effects 0.000 description 2
239000012091 fetal bovine serum Substances 0.000 description 2
GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 2
238000000799 fluorescence microscopy Methods 0.000 description 2
230000004927 fusion Effects 0.000 description 2
UIWYJDYFSGRHKR-UHFFFAOYSA-N gadolinium atom Chemical compound [Gd] UIWYJDYFSGRHKR-UHFFFAOYSA-N 0.000 description 2
239000000499 gel Substances 0.000 description 2
208000016361 genetic disease Diseases 0.000 description 2
239000008103 glucose Substances 0.000 description 2
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
230000002440 hepatic effect Effects 0.000 description 2
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 2
102000045539 human SSTR2 Human genes 0.000 description 2
238000003364 immunohistochemistry Methods 0.000 description 2
229960004657 indocyanine green Drugs 0.000 description 2
MOFVSTNWEDAEEK-UHFFFAOYSA-M indocyanine green Chemical compound [Na+].[O-]S(=O)(=O)CCCCN1C2=CC=C3C=CC=CC3=C2C(C)(C)C1=CC=CC=CC=CC1=[N+](CCCCS([O-])(=O)=O)C2=CC=C(C=CC=C3)C3=C2C1(C)C MOFVSTNWEDAEEK-UHFFFAOYSA-M 0.000 description 2
230000002757 inflammatory effect Effects 0.000 description 2
238000001802 infusion Methods 0.000 description 2
239000003112 inhibitor Substances 0.000 description 2
230000000977 initiatory effect Effects 0.000 description 2
229940047122 interleukins Drugs 0.000 description 2
230000002601 intratumoral effect Effects 0.000 description 2
238000001990 intravenous administration Methods 0.000 description 2
239000007951 isotonicity adjuster Substances 0.000 description 2
238000002372 labelling Methods 0.000 description 2
229940040129 luteinizing hormone Drugs 0.000 description 2
210000004698 lymphocyte Anatomy 0.000 description 2
230000005291 magnetic effect Effects 0.000 description 2
238000012423 maintenance Methods 0.000 description 2
239000011159 matrix material Substances 0.000 description 2
239000002609 medium Substances 0.000 description 2
230000004060 metabolic process Effects 0.000 description 2
244000005700 microbiome Species 0.000 description 2
210000003470 mitochondria Anatomy 0.000 description 2
206010051747 multiple endocrine neoplasia Diseases 0.000 description 2
230000001338 necrotic effect Effects 0.000 description 2
230000017095 negative regulation of cell growth Effects 0.000 description 2
230000001537 neural effect Effects 0.000 description 2
201000011519 neuroendocrine tumor Diseases 0.000 description 2
238000012758 nuclear staining Methods 0.000 description 2
210000004940 nucleus Anatomy 0.000 description 2
244000309459 oncolytic virus Species 0.000 description 2
210000003463 organelle Anatomy 0.000 description 2
230000035515 penetration Effects 0.000 description 2
230000010412 perfusion Effects 0.000 description 2
BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
229920005862 polyol Polymers 0.000 description 2
150000003077 polyols Chemical class 0.000 description 2
230000023603 positive regulation of transcription initiation, DNA-dependent Effects 0.000 description 2
239000000843 powder Substances 0.000 description 2
239000013615 primer Substances 0.000 description 2
229940097325 prolactin Drugs 0.000 description 2
230000002285 radioactive effect Effects 0.000 description 2
238000000163 radioactive labelling Methods 0.000 description 2
108010054624 red fluorescent protein Proteins 0.000 description 2
230000001850 reproductive effect Effects 0.000 description 2
230000002441 reversible effect Effects 0.000 description 2
238000012552 review Methods 0.000 description 2
PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 2
230000007017 scission Effects 0.000 description 2
238000011896 sensitive detection Methods 0.000 description 2
QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
230000019491 signal transduction Effects 0.000 description 2
108010013351 sodium-iodide symporter Proteins 0.000 description 2
210000001082 somatic cell Anatomy 0.000 description 2
229940075620 somatostatin analogue Drugs 0.000 description 2
108090000680 somatostatin receptor 5 Proteins 0.000 description 2
102000004115 somatostatin receptor 5 Human genes 0.000 description 2
238000000527 sonication Methods 0.000 description 2
230000009870 specific binding Effects 0.000 description 2
UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
239000000758 substrate Substances 0.000 description 2
239000006228 supernatant Substances 0.000 description 2
MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 2
RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
231100000331 toxic Toxicity 0.000 description 2
230000002588 toxic effect Effects 0.000 description 2
239000003053 toxin Substances 0.000 description 2
231100000765 toxin Toxicity 0.000 description 2
GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
239000002753 trypsin inhibitor Substances 0.000 description 2
108091005957 yellow fluorescent proteins Proteins 0.000 description 2
HEAUFJZALFKPBA-JPQUDPSNSA-N (3s)-3-[[(2s,3r)-2-[[(2s)-6-amino-2-[[(2s)-2-amino-3-(1h-imidazol-5-yl)propanoyl]amino]hexanoyl]amino]-3-hydroxybutanoyl]amino]-4-[[(2s)-1-[[(2s)-1-[[(2s)-1-[[2-[[(2s)-1-[[(2s)-1-amino-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amin Chemical compound C([C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(N)=O)C(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)C1=CC=CC=C1 HEAUFJZALFKPBA-JPQUDPSNSA-N 0.000 description 1
KKVYYGGCHJGEFJ-UHFFFAOYSA-N 1-n-(4-chlorophenyl)-6-methyl-5-n-[3-(7h-purin-6-yl)pyridin-2-yl]isoquinoline-1,5-diamine Chemical compound N=1C=CC2=C(NC=3C(=CC=CN=3)C=3C=4N=CNC=4N=CN=3)C(C)=CC=C2C=1NC1=CC=C(Cl)C=C1 KKVYYGGCHJGEFJ-UHFFFAOYSA-N 0.000 description 1
IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
238000010176 18-FDG-positron emission tomography Methods 0.000 description 1
ZIIUUSVHCHPIQD-UHFFFAOYSA-N 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NC1=CC=CC(C(F)(F)F)=C1 ZIIUUSVHCHPIQD-UHFFFAOYSA-N 0.000 description 1
FSPQCTGGIANIJZ-UHFFFAOYSA-N 2-[[(3,4-dimethoxyphenyl)-oxomethyl]amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide Chemical compound C1=C(OC)C(OC)=CC=C1C(=O)NC1=C(C(N)=O)C(CCCC2)=C2S1 FSPQCTGGIANIJZ-UHFFFAOYSA-N 0.000 description 1
KISWVXRQTGLFGD-UHFFFAOYSA-N 2-[[2-[[6-amino-2-[[2-[[2-[[5-amino-2-[[2-[[1-[2-[[6-amino-2-[(2,5-diamino-5-oxopentanoyl)amino]hexanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-5-(diaminomethylideneamino)p Chemical compound C1CCN(C(=O)C(CCCN=C(N)N)NC(=O)C(CCCCN)NC(=O)C(N)CCC(N)=O)C1C(=O)NC(CO)C(=O)NC(CCC(N)=O)C(=O)NC(CCCN=C(N)N)C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(C(=O)NC(CC(C)C)C(O)=O)CC1=CC=C(O)C=C1 KISWVXRQTGLFGD-UHFFFAOYSA-N 0.000 description 1
BNBQQYFXBLBYJK-UHFFFAOYSA-N 2-pyridin-2-yl-1,3-oxazole Chemical class C1=COC(C=2N=CC=CC=2)=N1 BNBQQYFXBLBYJK-UHFFFAOYSA-N 0.000 description 1
102100022464 5'-nucleotidase Human genes 0.000 description 1
108010029731 6-phosphogluconolactonase Proteins 0.000 description 1
102100031126 6-phosphogluconolactonase Human genes 0.000 description 1
STQGQHZAVUOBTE-UHFFFAOYSA-N 7-Cyan-hept-2t-en-4,6-diinsaeure Natural products C1=2C(O)=C3C(=O)C=4C(OC)=CC=CC=4C(=O)C3=C(O)C=2CC(O)(C(C)=O)CC1OC1CC(N)C(O)C(C)O1 STQGQHZAVUOBTE-UHFFFAOYSA-N 0.000 description 1
CFNMUZCFSDMZPQ-GHXNOFRVSA-N 7-[(z)-3-methyl-4-(4-methyl-5-oxo-2h-furan-2-yl)but-2-enoxy]chromen-2-one Chemical compound C=1C=C2C=CC(=O)OC2=CC=1OC/C=C(/C)CC1OC(=O)C(C)=C1 CFNMUZCFSDMZPQ-GHXNOFRVSA-N 0.000 description 1
ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
WFPZSXYXPSUOPY-ROYWQJLOSA-N ADP alpha-D-glucoside Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H]1O)O)N1C=2N=CN=C(C=2N=C1)N)OP(O)(=O)OP(O)(=O)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O WFPZSXYXPSUOPY-ROYWQJLOSA-N 0.000 description 1
WFPZSXYXPSUOPY-UHFFFAOYSA-N ADP-mannose Natural products C1=NC=2C(N)=NC=NC=2N1C(C(C1O)O)OC1COP(O)(=O)OP(O)(=O)OC1OC(CO)C(O)C(O)C1O WFPZSXYXPSUOPY-UHFFFAOYSA-N 0.000 description 1
102100028780 AP-1 complex subunit sigma-2 Human genes 0.000 description 1
108091006112 ATPases Proteins 0.000 description 1
108010059616 Activins Proteins 0.000 description 1
102000005606 Activins Human genes 0.000 description 1
229930024421 Adenine Natural products 0.000 description 1
GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
102000057290 Adenosine Triphosphatases Human genes 0.000 description 1
206010001258 Adenoviral infections Diseases 0.000 description 1
102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
108020004774 Alkaline Phosphatase Proteins 0.000 description 1
102000002260 Alkaline Phosphatase Human genes 0.000 description 1
108700028369 Alleles Proteins 0.000 description 1
208000024827 Alzheimer disease Diseases 0.000 description 1
101710154825 Aminoglycoside 3'-phosphotransferase Proteins 0.000 description 1
QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
239000004382 Amylase Substances 0.000 description 1
108010065511 Amylases Proteins 0.000 description 1
102000013142 Amylases Human genes 0.000 description 1
102400000344 Angiotensin-1 Human genes 0.000 description 1
101800000734 Angiotensin-1 Proteins 0.000 description 1
102400000345 Angiotensin-2 Human genes 0.000 description 1
101800000733 Angiotensin-2 Proteins 0.000 description 1
108010005853 Anti-Mullerian Hormone Proteins 0.000 description 1
208000019901 Anxiety disease Diseases 0.000 description 1
102000013918 Apolipoproteins E Human genes 0.000 description 1
108010025628 Apolipoproteins E Proteins 0.000 description 1
102100021569 Apoptosis regulator Bcl-2 Human genes 0.000 description 1
102100021986 Apoptosis-stimulating of p53 protein 2 Human genes 0.000 description 1
101710091620 Apoptosis-stimulating of p53 protein 2 Proteins 0.000 description 1
108091023037 Aptamer Proteins 0.000 description 1
101100281515 Arabidopsis thaliana FOX1 gene Proteins 0.000 description 1
102000004452 Arginase Human genes 0.000 description 1
108700024123 Arginases Proteins 0.000 description 1
239000004475 Arginine Substances 0.000 description 1
OXDZADMCOWPSOC-UHFFFAOYSA-N Argiprestocin Chemical compound N1C(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C(C(C)CC)NC(=O)C1CC1=CC=C(O)C=C1 OXDZADMCOWPSOC-UHFFFAOYSA-N 0.000 description 1
DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
101800001288 Atrial natriuretic factor Proteins 0.000 description 1
102400001282 Atrial natriuretic peptide Human genes 0.000 description 1
101800001890 Atrial natriuretic peptide Proteins 0.000 description 1
241001367053 Autographa gamma Species 0.000 description 1
208000032116 Autoimmune Experimental Encephalomyelitis Diseases 0.000 description 1
208000023275 Autoimmune disease Diseases 0.000 description 1
238000012935 Averaging Methods 0.000 description 1
108090001008 Avidin Proteins 0.000 description 1
101150033765 BAG1 gene Proteins 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
102100037674 Bis(5'-adenosyl)-triphosphatase Human genes 0.000 description 1
108010006654 Bleomycin Proteins 0.000 description 1
238000009010 Bradford assay Methods 0.000 description 1
108090000715 Brain-derived neurotrophic factor Proteins 0.000 description 1
102000004219 Brain-derived neurotrophic factor Human genes 0.000 description 1
238000006418 Brown reaction Methods 0.000 description 1
COVZYZSDYWQREU-UHFFFAOYSA-N Busulfan Chemical compound CS(=O)(=O)OCCCCOS(C)(=O)=O COVZYZSDYWQREU-UHFFFAOYSA-N 0.000 description 1
YNXLOPYTAAFMTN-SBUIBGKBSA-N C([C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(N)=O)C1=CC=C(O)C=C1 Chemical compound C([C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(N)=O)C1=CC=C(O)C=C1 YNXLOPYTAAFMTN-SBUIBGKBSA-N 0.000 description 1
239000002126 C01EB10 - Adenosine Substances 0.000 description 1
101150019620 CAD gene Proteins 0.000 description 1
229940126074 CDK kinase inhibitor Drugs 0.000 description 1
108090000932 Calcitonin Gene-Related Peptide Proteins 0.000 description 1
102000004414 Calcitonin Gene-Related Peptide Human genes 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
102000004031 Carboxy-Lyases Human genes 0.000 description 1
208000024172 Cardiovascular disease Diseases 0.000 description 1
102000003952 Caspase 3 Human genes 0.000 description 1
108090000397 Caspase 3 Proteins 0.000 description 1
102100035882 Catalase Human genes 0.000 description 1
108010053835 Catalase Proteins 0.000 description 1
108010059892 Cellulase Proteins 0.000 description 1
229920002101 Chitin Polymers 0.000 description 1
102100025841 Cholecystokinin Human genes 0.000 description 1
101800001982 Cholecystokinin Proteins 0.000 description 1
108010049048 Cholera Toxin Proteins 0.000 description 1
102000009016 Cholera Toxin Human genes 0.000 description 1
102000011022 Chorionic Gonadotropin Human genes 0.000 description 1
108010062540 Chorionic Gonadotropin Proteins 0.000 description 1
VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
108010005939 Ciliary Neurotrophic Factor Proteins 0.000 description 1
102100031614 Ciliary neurotrophic factor Human genes 0.000 description 1
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
102100022641 Coagulation factor IX Human genes 0.000 description 1
208000003322 Coinfection Diseases 0.000 description 1
208000006992 Color Vision Defects Diseases 0.000 description 1
208000035473 Communicable disease Diseases 0.000 description 1
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
102000015775 Core Binding Factor Alpha 1 Subunit Human genes 0.000 description 1
108010024682 Core Binding Factor Alpha 1 Subunit Proteins 0.000 description 1
101800000414 Corticotropin Proteins 0.000 description 1
108010022152 Corticotropin-Releasing Hormone Proteins 0.000 description 1
239000000055 Corticotropin-Releasing Hormone Substances 0.000 description 1
102000012289 Corticotropin-Releasing Hormone Human genes 0.000 description 1
102000004420 Creatine Kinase Human genes 0.000 description 1
108010042126 Creatine kinase Proteins 0.000 description 1
241000699802 Cricetulus griseus Species 0.000 description 1
108010025464 Cyclin-Dependent Kinase 4 Proteins 0.000 description 1
102000013701 Cyclin-Dependent Kinase 4 Human genes 0.000 description 1
102100033270 Cyclin-dependent kinase inhibitor 1 Human genes 0.000 description 1
102100034770 Cyclin-dependent kinase inhibitor 3 Human genes 0.000 description 1
102000003903 Cyclin-dependent kinases Human genes 0.000 description 1
108090000266 Cyclin-dependent kinases Proteins 0.000 description 1
CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 1
230000005778 DNA damage Effects 0.000 description 1
231100000277 DNA damage Toxicity 0.000 description 1
230000004543 DNA replication Effects 0.000 description 1
230000004568 DNA-binding Effects 0.000 description 1
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
101150049660 DRD2 gene Proteins 0.000 description 1
108010092160 Dactinomycin Proteins 0.000 description 1
102100038713 Death domain-containing protein CRADD Human genes 0.000 description 1
108010086291 Deubiquitinating Enzyme CYLD Proteins 0.000 description 1
229920002307 Dextran Polymers 0.000 description 1
102100034581 Dihydroorotase Human genes 0.000 description 1
108010044266 Dopamine Plasma Membrane Transport Proteins Proteins 0.000 description 1
101100506758 Drosophila melanogaster hid gene Proteins 0.000 description 1
102100037570 Dual specificity protein phosphatase 16 Human genes 0.000 description 1
206010013883 Dwarfism Diseases 0.000 description 1
102000012199 E3 ubiquitin-protein ligase Mdm2 Human genes 0.000 description 1
108050002772 E3 ubiquitin-protein ligase Mdm2 Proteins 0.000 description 1
102000001301 EGF receptor Human genes 0.000 description 1
238000002965 ELISA Methods 0.000 description 1
238000012286 ELISA Assay Methods 0.000 description 1
101710121765 Endo-1,4-beta-xylanase Proteins 0.000 description 1
102000002045 Endothelin Human genes 0.000 description 1
108050009340 Endothelin Proteins 0.000 description 1
101710091045 Envelope protein Proteins 0.000 description 1
108090000371 Esterases Proteins 0.000 description 1
241000206602 Eukaryota Species 0.000 description 1
101710196289 Eukaryotic translation initiation factor 2-alpha kinase 1 Proteins 0.000 description 1
BPNZYADGDZPRTK-UDUYQYQQSA-N Exametazime Chemical compound O/N=C(\C)[C@@H](C)NCC(C)(C)CN[C@H](C)C(\C)=N\O BPNZYADGDZPRTK-UDUYQYQQSA-N 0.000 description 1
101150021185 FGF gene Proteins 0.000 description 1
108010076282 Factor IX Proteins 0.000 description 1
108010054218 Factor VIII Proteins 0.000 description 1
102000001690 Factor VIII Human genes 0.000 description 1
102000018233 Fibroblast Growth Factor Human genes 0.000 description 1
108050007372 Fibroblast Growth Factor Proteins 0.000 description 1
108090000386 Fibroblast Growth Factor 1 Proteins 0.000 description 1
102100031706 Fibroblast growth factor 1 Human genes 0.000 description 1
102100024785 Fibroblast growth factor 2 Human genes 0.000 description 1
108090000379 Fibroblast growth factor 2 Proteins 0.000 description 1
GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 1
241000233866 Fungi Species 0.000 description 1
102100022360 GATOR complex protein NPRL2 Human genes 0.000 description 1
108700012941 GNRH1 Proteins 0.000 description 1
102000013446 GTP Phosphohydrolases Human genes 0.000 description 1
102100037948 GTP-binding protein Di-Ras3 Human genes 0.000 description 1
102100029974 GTPase HRas Human genes 0.000 description 1
102100030708 GTPase KRas Human genes 0.000 description 1
102100039788 GTPase NRas Human genes 0.000 description 1
108091006109 GTPases Proteins 0.000 description 1
108010093031 Galactosidases Proteins 0.000 description 1
102000002464 Galactosidases Human genes 0.000 description 1
102400001370 Galanin Human genes 0.000 description 1
101800002068 Galanin Proteins 0.000 description 1
102100039556 Galectin-4 Human genes 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
108700007698 Genetic Terminator Regions Proteins 0.000 description 1
102000004038 Glia Maturation Factor Human genes 0.000 description 1
108090000495 Glia Maturation Factor Proteins 0.000 description 1
102400000321 Glucagon Human genes 0.000 description 1
108060003199 Glucagon Proteins 0.000 description 1
108010088406 Glucagon-Like Peptides Proteins 0.000 description 1
108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 1
239000004366 Glucose oxidase Substances 0.000 description 1
108010015776 Glucose oxidase Proteins 0.000 description 1
108010086800 Glucose-6-Phosphatase Proteins 0.000 description 1
102000003638 Glucose-6-Phosphatase Human genes 0.000 description 1
108010018962 Glucosephosphate Dehydrogenase Proteins 0.000 description 1
108010015451 Glutaryl-CoA Dehydrogenase Proteins 0.000 description 1
102100028603 Glutaryl-CoA dehydrogenase, mitochondrial Human genes 0.000 description 1
102000005720 Glutathione transferase Human genes 0.000 description 1
108010070675 Glutathione transferase Proteins 0.000 description 1
239000004471 Glycine Substances 0.000 description 1
102000004327 Glycine dehydrogenase (decarboxylating) Human genes 0.000 description 1
108090000826 Glycine dehydrogenase (decarboxylating) Proteins 0.000 description 1
102000003886 Glycoproteins Human genes 0.000 description 1
108090000288 Glycoproteins Proteins 0.000 description 1
239000000579 Gonadotropin-Releasing Hormone Substances 0.000 description 1
102000006771 Gonadotropins Human genes 0.000 description 1
108010086677 Gonadotropins Proteins 0.000 description 1
108010078321 Guanylate Cyclase Proteins 0.000 description 1
102000014469 Guanylate cyclase Human genes 0.000 description 1
208000031886 HIV Infections Diseases 0.000 description 1
208000037357 HIV infectious disease Diseases 0.000 description 1
102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 1
208000032843 Hemorrhage Diseases 0.000 description 1
208000002972 Hepatolenticular Degeneration Diseases 0.000 description 1
208000009889 Herpes Simplex Diseases 0.000 description 1
108010027412 Histocompatibility Antigens Class II Proteins 0.000 description 1
102000018713 Histocompatibility Antigens Class II Human genes 0.000 description 1
102100022103 Histone-lysine N-methyltransferase 2A Human genes 0.000 description 1
101000678236 Homo sapiens 5'-nucleotidase Proteins 0.000 description 1
101000768016 Homo sapiens AP-1 complex subunit sigma-2 Proteins 0.000 description 1
101000971171 Homo sapiens Apoptosis regulator Bcl-2 Proteins 0.000 description 1
101000944380 Homo sapiens Cyclin-dependent kinase inhibitor 1 Proteins 0.000 description 1
101000945639 Homo sapiens Cyclin-dependent kinase inhibitor 3 Proteins 0.000 description 1
101000957914 Homo sapiens Death domain-containing protein CRADD Proteins 0.000 description 1
101000881117 Homo sapiens Dual specificity protein phosphatase 16 Proteins 0.000 description 1
101000851181 Homo sapiens Epidermal growth factor receptor Proteins 0.000 description 1
101001010910 Homo sapiens Estrogen receptor beta Proteins 0.000 description 1
101000951235 Homo sapiens GTP-binding protein Di-Ras3 Proteins 0.000 description 1
101000584633 Homo sapiens GTPase HRas Proteins 0.000 description 1
101000744505 Homo sapiens GTPase NRas Proteins 0.000 description 1
101000608765 Homo sapiens Galectin-4 Proteins 0.000 description 1
101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 1
101000882390 Homo sapiens Histone acetyltransferase p300 Proteins 0.000 description 1
101000962530 Homo sapiens Hyaluronidase-1 Proteins 0.000 description 1
101000962526 Homo sapiens Hyaluronidase-2 Proteins 0.000 description 1
101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 description 1
101001034314 Homo sapiens Lactadherin Proteins 0.000 description 1
101000835893 Homo sapiens Mothers against decapentaplegic homolog 4 Proteins 0.000 description 1
101000583702 Homo sapiens Pleckstrin homology-like domain family A member 2 Proteins 0.000 description 1
101000876829 Homo sapiens Protein C-ets-1 Proteins 0.000 description 1
101000898093 Homo sapiens Protein C-ets-2 Proteins 0.000 description 1
101000585703 Homo sapiens Protein L-Myc Proteins 0.000 description 1
101000739160 Homo sapiens Secretoglobin family 3A member 1 Proteins 0.000 description 1
101000777277 Homo sapiens Serine/threonine-protein kinase Chk2 Proteins 0.000 description 1
101000800488 Homo sapiens T-cell leukemia homeobox protein 1 Proteins 0.000 description 1
101000837626 Homo sapiens Thyroid hormone receptor alpha Proteins 0.000 description 1
101000813738 Homo sapiens Transcription factor ETV6 Proteins 0.000 description 1
101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 description 1
101000611023 Homo sapiens Tumor necrosis factor receptor superfamily member 6 Proteins 0.000 description 1
101000912503 Homo sapiens Tyrosine-protein kinase Fgr Proteins 0.000 description 1
101001022129 Homo sapiens Tyrosine-protein kinase Fyn Proteins 0.000 description 1
101000740759 Homo sapiens Voltage-dependent calcium channel subunit alpha-2/delta-2 Proteins 0.000 description 1
101000804798 Homo sapiens Werner syndrome ATP-dependent helicase Proteins 0.000 description 1
101001127470 Homo sapiens p53 apoptosis effector related to PMP-22 Proteins 0.000 description 1
108010000521 Human Growth Hormone Proteins 0.000 description 1
102000002265 Human Growth Hormone Human genes 0.000 description 1
239000000854 Human Growth Hormone Substances 0.000 description 1
241000598171 Human adenovirus sp. Species 0.000 description 1
108010003272 Hyaluronate lyase Proteins 0.000 description 1
102100039283 Hyaluronidase-1 Human genes 0.000 description 1
102100039285 Hyaluronidase-2 Human genes 0.000 description 1
102000001974 Hyaluronidases Human genes 0.000 description 1
102000004157 Hydrolases Human genes 0.000 description 1
108090000604 Hydrolases Proteins 0.000 description 1
229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
206010020584 Hypercalcaemia of malignancy Diseases 0.000 description 1
102100031612 Hypermethylated in cancer 1 protein Human genes 0.000 description 1
101710133850 Hypermethylated in cancer 1 protein Proteins 0.000 description 1
206010020772 Hypertension Diseases 0.000 description 1
206010021143 Hypoxia Diseases 0.000 description 1
CZGUSIXMZVURDU-JZXHSEFVSA-N Ile(5)-angiotensin II Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C([O-])=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=[NH2+])NC(=O)[C@@H]([NH3+])CC([O-])=O)C(C)C)C1=CC=C(O)C=C1 CZGUSIXMZVURDU-JZXHSEFVSA-N 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
206010061218 Inflammation Diseases 0.000 description 1
241000712431 Influenza A virus Species 0.000 description 1
102000003781 Inhibitor of growth protein 1 Human genes 0.000 description 1
108090000191 Inhibitor of growth protein 1 Proteins 0.000 description 1
108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
108010061833 Integrases Proteins 0.000 description 1
102000004289 Interferon regulatory factor 1 Human genes 0.000 description 1
108090000890 Interferon regulatory factor 1 Proteins 0.000 description 1
108090000176 Interleukin-13 Proteins 0.000 description 1
108090000172 Interleukin-15 Proteins 0.000 description 1
102000003812 Interleukin-15 Human genes 0.000 description 1
101800003050 Interleukin-16 Proteins 0.000 description 1
102000049772 Interleukin-16 Human genes 0.000 description 1
108050003558 Interleukin-17 Proteins 0.000 description 1
102000013691 Interleukin-17 Human genes 0.000 description 1
102000003810 Interleukin-18 Human genes 0.000 description 1
108090000171 Interleukin-18 Proteins 0.000 description 1
102100039879 Interleukin-19 Human genes 0.000 description 1
108050009288 Interleukin-19 Proteins 0.000 description 1
OIRFJRBSRORBCM-UHFFFAOYSA-N Iopanoic acid Chemical compound CCC(C(O)=O)CC1=C(I)C=C(I)C(N)=C1I OIRFJRBSRORBCM-UHFFFAOYSA-N 0.000 description 1
UXIGWFXRQKWHHA-UHFFFAOYSA-N Iotalamic acid Chemical compound CNC(=O)C1=C(I)C(NC(C)=O)=C(I)C(C(O)=O)=C1I UXIGWFXRQKWHHA-UHFFFAOYSA-N 0.000 description 1
102000036770 Islet Amyloid Polypeptide Human genes 0.000 description 1
108010041872 Islet Amyloid Polypeptide Proteins 0.000 description 1
108090000769 Isomerases Proteins 0.000 description 1
102000004195 Isomerases Human genes 0.000 description 1
108010013792 Isovaleryl-CoA Dehydrogenase Proteins 0.000 description 1
102100025392 Isovaleryl-CoA dehydrogenase, mitochondrial Human genes 0.000 description 1
102000002397 Kinins Human genes 0.000 description 1
108010093008 Kinins Proteins 0.000 description 1
102100020880 Kit ligand Human genes 0.000 description 1
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
XNSAINXGIQZQOO-UHFFFAOYSA-N L-pyroglutamyl-L-histidyl-L-proline amide Natural products NC(=O)C1CCCN1C(=O)C(NC(=O)C1NC(=O)CC1)CC1=CN=CN1 XNSAINXGIQZQOO-UHFFFAOYSA-N 0.000 description 1
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
108010001831 LDL receptors Proteins 0.000 description 1
102100039648 Lactadherin Human genes 0.000 description 1
108010059881 Lactase Proteins 0.000 description 1
102000002297 Laminin Receptors Human genes 0.000 description 1
108010000851 Laminin Receptors Proteins 0.000 description 1
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
102100020872 Leucyl-cystinyl aminopeptidase Human genes 0.000 description 1
102000004882 Lipase Human genes 0.000 description 1
108090001060 Lipase Proteins 0.000 description 1
239000004367 Lipase Substances 0.000 description 1
102000003820 Lipoxygenases Human genes 0.000 description 1
108090000128 Lipoxygenases Proteins 0.000 description 1
102100024640 Low-density lipoprotein receptor Human genes 0.000 description 1
108010074338 Lymphokines Proteins 0.000 description 1
102000008072 Lymphokines Human genes 0.000 description 1
239000004472 Lysine Substances 0.000 description 1
102000043136 MAP kinase family Human genes 0.000 description 1
108091054455 MAP kinase family Proteins 0.000 description 1
108091054437 MHC class I family Proteins 0.000 description 1
102000043129 MHC class I family Human genes 0.000 description 1
108700012912 MYCN Proteins 0.000 description 1
101150022024 MYCN gene Proteins 0.000 description 1
101710175625 Maltose/maltodextrin-binding periplasmic protein Proteins 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
238000000585 Mann–Whitney U test Methods 0.000 description 1
101150094768 Mcam gene Proteins 0.000 description 1
239000000637 Melanocyte-Stimulating Hormone Substances 0.000 description 1
101710151321 Melanostatin Proteins 0.000 description 1
102000018697 Membrane Proteins Human genes 0.000 description 1
108010052285 Membrane Proteins Proteins 0.000 description 1
208000008948 Menkes Kinky Hair Syndrome Diseases 0.000 description 1
208000012583 Menkes disease Diseases 0.000 description 1
206010027452 Metastases to bone Diseases 0.000 description 1
108010085747 Methylmalonyl-CoA Decarboxylase Proteins 0.000 description 1
102000019010 Methylmalonyl-CoA Mutase Human genes 0.000 description 1
108010051862 Methylmalonyl-CoA mutase Proteins 0.000 description 1
108060004795 Methyltransferase Proteins 0.000 description 1
101710169105 Minor spike protein Proteins 0.000 description 1
101710081079 Minor spike protein H Proteins 0.000 description 1
229930192392 Mitomycin Natural products 0.000 description 1
102000008109 Mixed Function Oxygenases Human genes 0.000 description 1
108010074633 Mixed Function Oxygenases Proteins 0.000 description 1
241000713869 Moloney murine leukemia virus Species 0.000 description 1
ZOKXTWBITQBERF-AKLPVKDBSA-N Molybdenum Mo-99 Chemical compound [99Mo] ZOKXTWBITQBERF-AKLPVKDBSA-N 0.000 description 1
108010050619 Monokines Proteins 0.000 description 1
102000013967 Monokines Human genes 0.000 description 1
206010073149 Multiple endocrine neoplasia Type 2 Diseases 0.000 description 1
108010014251 Muramidase Proteins 0.000 description 1
102000016943 Muramidase Human genes 0.000 description 1
101100381978 Mus musculus Braf gene Proteins 0.000 description 1
101000978776 Mus musculus Neurogenic locus notch homolog protein 1 Proteins 0.000 description 1
101100523604 Mus musculus Rassf5 gene Proteins 0.000 description 1
101710135898 Myc proto-oncogene protein Proteins 0.000 description 1
102000047918 Myelin Basic Human genes 0.000 description 1
101710107068 Myelin basic protein Proteins 0.000 description 1
102100030626 Myosin-binding protein H Human genes 0.000 description 1
101710139548 Myosin-binding protein H Proteins 0.000 description 1
NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 1
101001055320 Myxine glutinosa Insulin-like growth factor Proteins 0.000 description 1
108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
108700026495 N-Myc Proto-Oncogene Proteins 0.000 description 1
102100030124 N-myc proto-oncogene protein Human genes 0.000 description 1
206010028851 Necrosis Diseases 0.000 description 1
241001045988 Neogene Species 0.000 description 1
102000015336 Nerve Growth Factor Human genes 0.000 description 1
102000007072 Nerve Growth Factors Human genes 0.000 description 1
206010029260 Neuroblastoma Diseases 0.000 description 1
102400000097 Neurokinin A Human genes 0.000 description 1
101800000399 Neurokinin A Proteins 0.000 description 1
208000025966 Neurological disease Diseases 0.000 description 1
102400000064 Neuropeptide Y Human genes 0.000 description 1
108010018674 Neurophysins Proteins 0.000 description 1
102000002710 Neurophysins Human genes 0.000 description 1
108090000742 Neurotrophin 3 Proteins 0.000 description 1
239000000020 Nitrocellulose Substances 0.000 description 1
101150074217 Nprl2 gene Proteins 0.000 description 1
108091005461 Nucleic proteins Proteins 0.000 description 1
102100025193 OTU domain-containing protein 4 Human genes 0.000 description 1
108050002069 Olfactory receptors Proteins 0.000 description 1
102000010175 Opsin Human genes 0.000 description 1
108050001704 Opsin Proteins 0.000 description 1
102400000050 Oxytocin Human genes 0.000 description 1
101800000989 Oxytocin Proteins 0.000 description 1
XNOPRXBHLZRZKH-UHFFFAOYSA-N Oxytocin Natural products N1C(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CC(C)C)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C(C(C)CC)NC(=O)C1CC1=CC=C(O)C=C1 XNOPRXBHLZRZKH-UHFFFAOYSA-N 0.000 description 1
229930012538 Paclitaxel Natural products 0.000 description 1
102400000203 Pancreastatin Human genes 0.000 description 1
101800005322 Pancreastatin Proteins 0.000 description 1
229930040373 Paraformaldehyde Natural products 0.000 description 1
102000003982 Parathyroid hormone Human genes 0.000 description 1
108090000445 Parathyroid hormone Proteins 0.000 description 1
208000018737 Parkinson disease Diseases 0.000 description 1
229930182555 Penicillin Natural products 0.000 description 1
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
102000015731 Peptide Hormones Human genes 0.000 description 1
108010038988 Peptide Hormones Proteins 0.000 description 1
108010088847 Peptide YY Proteins 0.000 description 1
102100029909 Peptide YY Human genes 0.000 description 1
102100039087 Peptidyl-alpha-hydroxyglycine alpha-amidating lyase Human genes 0.000 description 1
101710189920 Peptidyl-alpha-hydroxyglycine alpha-amidating lyase Proteins 0.000 description 1
102000003992 Peroxidases Human genes 0.000 description 1
101710114878 Phospholipase A-2-activating protein Proteins 0.000 description 1
108010064785 Phospholipases Proteins 0.000 description 1
102000015439 Phospholipases Human genes 0.000 description 1
108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
102000014750 Phosphorylase Kinase Human genes 0.000 description 1
108010064071 Phosphorylase Kinase Proteins 0.000 description 1
241000709664 Picornaviridae Species 0.000 description 1
102100022427 Plasmalemma vesicle-associated protein Human genes 0.000 description 1
101710193105 Plasmalemma vesicle-associated protein Proteins 0.000 description 1
102100030926 Pleckstrin homology-like domain family A member 2 Human genes 0.000 description 1
208000000474 Poliomyelitis Diseases 0.000 description 1
239000002202 Polyethylene glycol Substances 0.000 description 1
108010059820 Polygalacturonase Proteins 0.000 description 1
KQHKSGRIBYJYFX-UHFFFAOYSA-J Ponceau S Chemical compound [Na+].[Na+].[Na+].[Na+].Oc1c(cc2cc(ccc2c1N=Nc1ccc(cc1S([O-])(=O)=O)N=Nc1ccc(cc1)S([O-])(=O)=O)S([O-])(=O)=O)S([O-])(=O)=O KQHKSGRIBYJYFX-UHFFFAOYSA-J 0.000 description 1
QSHWIQZFGQKFMA-UHFFFAOYSA-N Porphobilinogen Natural products NCC=1NC=C(CCC(O)=O)C=1CC(O)=O QSHWIQZFGQKFMA-UHFFFAOYSA-N 0.000 description 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
108010035004 Prephenate Dehydrogenase Proteins 0.000 description 1
102100027467 Pro-opiomelanocortin Human genes 0.000 description 1
108010076181 Proinsulin Proteins 0.000 description 1
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
102100038277 Prostaglandin G/H synthase 1 Human genes 0.000 description 1
108050003243 Prostaglandin G/H synthase 1 Proteins 0.000 description 1
239000004365 Protease Substances 0.000 description 1
229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
102100035251 Protein C-ets-1 Human genes 0.000 description 1
102100021890 Protein C-ets-2 Human genes 0.000 description 1
102000001253 Protein Kinase Human genes 0.000 description 1
102100030128 Protein L-Myc Human genes 0.000 description 1
108010076504 Protein Sorting Signals Proteins 0.000 description 1
102000002727 Protein Tyrosine Phosphatase Human genes 0.000 description 1
101710188315 Protein X Proteins 0.000 description 1
102100027584 Protein c-Fos Human genes 0.000 description 1
102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 1
108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 1
208000028017 Psychotic disease Diseases 0.000 description 1
KDCGOANMDULRCW-UHFFFAOYSA-N Purine Natural products N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 1
CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
108010053763 Pyruvate Carboxylase Proteins 0.000 description 1
102100039895 Pyruvate carboxylase, mitochondrial Human genes 0.000 description 1
108091034057 RNA (poly(A)) Proteins 0.000 description 1
102000009572 RNA Polymerase II Human genes 0.000 description 1
108010009460 RNA Polymerase II Proteins 0.000 description 1
239000013616 RNA primer Substances 0.000 description 1
230000006819 RNA synthesis Effects 0.000 description 1
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
101000868151 Rattus norvegicus Somatotropin Proteins 0.000 description 1
102100020718 Receptor-type tyrosine-protein kinase FLT3 Human genes 0.000 description 1
101710151245 Receptor-type tyrosine-protein kinase FLT3 Proteins 0.000 description 1
102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
102000018120 Recombinases Human genes 0.000 description 1
108010091086 Recombinases Proteins 0.000 description 1
108090000103 Relaxin Proteins 0.000 description 1
102000003743 Relaxin Human genes 0.000 description 1
208000001647 Renal Insufficiency Diseases 0.000 description 1
208000006265 Renal cell carcinoma Diseases 0.000 description 1
241000702263 Reovirus sp. Species 0.000 description 1
208000007014 Retinitis pigmentosa Diseases 0.000 description 1
102000004330 Rhodopsin Human genes 0.000 description 1
108090000820 Rhodopsin Proteins 0.000 description 1
108010083644 Ribonucleases Proteins 0.000 description 1
102000006382 Ribonucleases Human genes 0.000 description 1
108010039491 Ricin Proteins 0.000 description 1
101150019443 SMAD4 gene Proteins 0.000 description 1
206010039491 Sarcoma Diseases 0.000 description 1
108010086019 Secretin Proteins 0.000 description 1
102100037505 Secretin Human genes 0.000 description 1
BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
102100031075 Serine/threonine-protein kinase Chk2 Human genes 0.000 description 1
108700028909 Serum Amyloid A Proteins 0.000 description 1
102000054727 Serum Amyloid A Human genes 0.000 description 1
108010045517 Serum Amyloid P-Component Proteins 0.000 description 1
108010032838 Sialoglycoproteins Proteins 0.000 description 1
102000007365 Sialoglycoproteins Human genes 0.000 description 1
208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
108700031298 Smad4 Proteins 0.000 description 1
102100033928 Sodium-dependent dopamine transporter Human genes 0.000 description 1
206010071051 Soft tissue mass Diseases 0.000 description 1
102100032889 Sortilin Human genes 0.000 description 1
108010061312 Sphingomyelin Phosphodiesterase Proteins 0.000 description 1
102000011971 Sphingomyelin Phosphodiesterase Human genes 0.000 description 1
108010039445 Stem Cell Factor Proteins 0.000 description 1
108010090804 Streptavidin Proteins 0.000 description 1
102100033111 T-cell leukemia homeobox protein 1 Human genes 0.000 description 1
GKLVYJBZJHMRIY-OUBTZVSYSA-N Technetium-99 Chemical compound [99Tc] GKLVYJBZJHMRIY-OUBTZVSYSA-N 0.000 description 1
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
239000004473 Threonine Substances 0.000 description 1
108090000190 Thrombin Proteins 0.000 description 1
108060008245 Thrombospondin Proteins 0.000 description 1
102000002938 Thrombospondin Human genes 0.000 description 1
102100028702 Thyroid hormone receptor alpha Human genes 0.000 description 1
239000000627 Thyrotropin-Releasing Hormone Substances 0.000 description 1
102400000336 Thyrotropin-releasing hormone Human genes 0.000 description 1
101800004623 Thyrotropin-releasing hormone Proteins 0.000 description 1
102100030951 Tissue factor pathway inhibitor Human genes 0.000 description 1
102100024026 Transcription factor E2F1 Human genes 0.000 description 1
102100039580 Transcription factor ETV6 Human genes 0.000 description 1
102100030780 Transcriptional activator Myb Human genes 0.000 description 1
101710150448 Transcriptional regulator Myc Proteins 0.000 description 1
102100021728 Transmembrane reductase CYB561D2 Human genes 0.000 description 1
239000007983 Tris buffer Substances 0.000 description 1
101001037292 Triticum aestivum Bowman-Birk type trypsin inhibitor Proteins 0.000 description 1
239000013504 Triton X-100 Substances 0.000 description 1
229920004890 Triton X-100 Polymers 0.000 description 1
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
108010078814 Tumor Suppressor Protein p53 Proteins 0.000 description 1
102100040247 Tumor necrosis factor Human genes 0.000 description 1
102100040403 Tumor necrosis factor receptor superfamily member 6 Human genes 0.000 description 1
206010054094 Tumour necrosis Diseases 0.000 description 1
102000014384 Type C Phospholipases Human genes 0.000 description 1
108010079194 Type C Phospholipases Proteins 0.000 description 1
102100026150 Tyrosine-protein kinase Fgr Human genes 0.000 description 1
102100035221 Tyrosine-protein kinase Fyn Human genes 0.000 description 1
102100024036 Tyrosine-protein kinase Lck Human genes 0.000 description 1
102100026857 Tyrosine-protein kinase Lyn Human genes 0.000 description 1
108010058532 UTP-hexose-1-phosphate uridylyltransferase Proteins 0.000 description 1
102000006321 UTP-hexose-1-phosphate uridylyltransferase Human genes 0.000 description 1
102100024250 Ubiquitin carboxyl-terminal hydrolase CYLD Human genes 0.000 description 1
102000003848 Uteroglobin Human genes 0.000 description 1
108090000203 Uteroglobin Proteins 0.000 description 1
206010046865 Vaccinia virus infection Diseases 0.000 description 1
108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 1
108010003205 Vasoactive Intestinal Peptide Proteins 0.000 description 1
102400000015 Vasoactive intestinal peptide Human genes 0.000 description 1
108010004977 Vasopressins Proteins 0.000 description 1
102000002852 Vasopressins Human genes 0.000 description 1
101800003024 Vasotocin Proteins 0.000 description 1
241000710959 Venezuelan equine encephalitis virus Species 0.000 description 1
108010003533 Viral Envelope Proteins Proteins 0.000 description 1
101710145727 Viral Fc-gamma receptor-like protein UL119 Proteins 0.000 description 1
102100037058 Voltage-dependent calcium channel subunit alpha-2/delta-2 Human genes 0.000 description 1
108700020467 WT1 Proteins 0.000 description 1
101150084041 WT1 gene Proteins 0.000 description 1
208000018839 Wilson disease Diseases 0.000 description 1
108010027570 Xanthine phosphoribosyltransferase Proteins 0.000 description 1
HMNZFMSWFCAGGW-XPWSMXQVSA-N [3-[hydroxy(2-hydroxyethoxy)phosphoryl]oxy-2-[(e)-octadec-9-enoyl]oxypropyl] (e)-octadec-9-enoate Chemical compound CCCCCCCC\C=C\CCCCCCCC(=O)OCC(COP(O)(=O)OCCO)OC(=O)CCCCCCC\C=C\CCCCCCCC HMNZFMSWFCAGGW-XPWSMXQVSA-N 0.000 description 1
210000001015 abdomen Anatomy 0.000 description 1
239000003070 absorption delaying agent Substances 0.000 description 1
OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
229960004373 acetylcholine Drugs 0.000 description 1
RJURFGZVJUQBHK-IIXSONLDSA-N actinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-IIXSONLDSA-N 0.000 description 1
230000003213 activating effect Effects 0.000 description 1
239000013543 active substance Substances 0.000 description 1
239000000488 activin Substances 0.000 description 1
108010036419 acyl-(acyl-carrier-protein)desaturase Proteins 0.000 description 1
229960000643 adenine Drugs 0.000 description 1
229960005305 adenosine Drugs 0.000 description 1
239000000464 adrenergic agent Substances 0.000 description 1
239000000443 aerosol Substances 0.000 description 1
235000004279 alanine Nutrition 0.000 description 1
230000000172 allergic effect Effects 0.000 description 1
YVPYQUNUQOZFHG-UHFFFAOYSA-N amidotrizoic acid Chemical compound CC(=O)NC1=C(I)C(NC(C)=O)=C(I)C(C(O)=O)=C1I YVPYQUNUQOZFHG-UHFFFAOYSA-N 0.000 description 1
235000019418 amylase Nutrition 0.000 description 1
ORWYRWWVDCYOMK-HBZPZAIKSA-N angiotensin I Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C1=CC=C(O)C=C1 ORWYRWWVDCYOMK-HBZPZAIKSA-N 0.000 description 1
229950006323 angiotensin ii Drugs 0.000 description 1
238000010171 animal model Methods 0.000 description 1
230000000844 anti-bacterial effect Effects 0.000 description 1
230000001093 anti-cancer Effects 0.000 description 1
239000000868 anti-mullerian hormone Substances 0.000 description 1
230000036506 anxiety Effects 0.000 description 1
238000003782 apoptosis assay Methods 0.000 description 1
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
229910052785 arsenic Inorganic materials 0.000 description 1
RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
235000009582 asparagine Nutrition 0.000 description 1
229960001230 asparagine Drugs 0.000 description 1
235000003704 aspartic acid Nutrition 0.000 description 1
208000006673 asthma Diseases 0.000 description 1
101150036080 at gene Proteins 0.000 description 1
208000010668 atopic eczema Diseases 0.000 description 1
VSRXQHXAPYXROS-UHFFFAOYSA-N azanide;cyclobutane-1,1-dicarboxylic acid;platinum(2+) Chemical compound [NH2-].[NH2-].[Pt+2].OC(=O)C1(C(O)=O)CCC1 VSRXQHXAPYXROS-UHFFFAOYSA-N 0.000 description 1
210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 1
238000003287 bathing Methods 0.000 description 1
108700000711 bcl-X Proteins 0.000 description 1
102000055104 bcl-X Human genes 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
230000001588 bifunctional effect Effects 0.000 description 1
239000003012 bilayer membrane Substances 0.000 description 1
230000003115 biocidal effect Effects 0.000 description 1
230000033228 biological regulation Effects 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
108010005713 bis(5'-adenosyl)triphosphatase Proteins 0.000 description 1
229960001561 bleomycin Drugs 0.000 description 1
OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
238000007469 bone scintigraphy Methods 0.000 description 1
210000004958 brain cell Anatomy 0.000 description 1
201000008275 breast carcinoma Diseases 0.000 description 1
229960002092 busulfan Drugs 0.000 description 1
230000009992 cAMP activation Effects 0.000 description 1
239000011575 calcium Substances 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
239000001506 calcium phosphate Substances 0.000 description 1
229910000389 calcium phosphate Inorganic materials 0.000 description 1
235000011010 calcium phosphates Nutrition 0.000 description 1
102000028861 calmodulin binding Human genes 0.000 description 1
108091000084 calmodulin binding Proteins 0.000 description 1
125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 1
229960004562 carboplatin Drugs 0.000 description 1
208000002458 carcinoid tumor Diseases 0.000 description 1
NSQLIUXCMFBZME-MPVJKSABSA-N carperitide Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CSSC[C@@H](C(=O)N1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)=O)[C@@H](C)CC)C1=CC=CC=C1 NSQLIUXCMFBZME-MPVJKSABSA-N 0.000 description 1
CZPLANDPABRVHX-UHFFFAOYSA-N cascade blue Chemical compound C=1C2=CC=CC=C2C(NCC)=CC=1C(C=1C=CC(=CC=1)N(CC)CC)=C1C=CC(=[N+](CC)CC)C=C1 CZPLANDPABRVHX-UHFFFAOYSA-N 0.000 description 1
PTIUZRZHZRYCJE-UHFFFAOYSA-N cascade yellow Chemical compound C1=C(S([O-])(=O)=O)C(OC)=CC=C1C1=CN=C(C=2C=C[N+](CC=3C=C(C=CC=3)C(=O)ON3C(CCC3=O)=O)=CC=2)O1 PTIUZRZHZRYCJE-UHFFFAOYSA-N 0.000 description 1
230000003197 catalytic effect Effects 0.000 description 1
238000004113 cell culture Methods 0.000 description 1
230000032823 cell division Effects 0.000 description 1
230000010261 cell growth Effects 0.000 description 1
239000013592 cell lysate Substances 0.000 description 1
230000010001 cellular homeostasis Effects 0.000 description 1
230000030570 cellular localization Effects 0.000 description 1
229940106157 cellulase Drugs 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
210000003169 central nervous system Anatomy 0.000 description 1
230000003788 cerebral perfusion Effects 0.000 description 1
150000005829 chemical entities Chemical class 0.000 description 1
238000007385 chemical modification Methods 0.000 description 1
239000007795 chemical reaction product Substances 0.000 description 1
230000035605 chemotaxis Effects 0.000 description 1
210000004978 chinese hamster ovary cell Anatomy 0.000 description 1
229960004630 chlorambucil Drugs 0.000 description 1
JCKYGMPEJWAADB-UHFFFAOYSA-N chlorambucil Chemical compound OC(=O)CCCC1=CC=C(N(CCCl)CCCl)C=C1 JCKYGMPEJWAADB-UHFFFAOYSA-N 0.000 description 1
229960004926 chlorobutanol Drugs 0.000 description 1
210000003763 chloroplast Anatomy 0.000 description 1
235000012000 cholesterol Nutrition 0.000 description 1
229940015047 chorionic gonadotropin Drugs 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
229910052804 chromium Inorganic materials 0.000 description 1
239000011651 chromium Substances 0.000 description 1
230000002759 chromosomal effect Effects 0.000 description 1
DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 1
229960004316 cisplatin Drugs 0.000 description 1
230000004186 co-expression Effects 0.000 description 1
238000012761 co-transfection Methods 0.000 description 1
239000011248 coating agent Substances 0.000 description 1
229910017052 cobalt Inorganic materials 0.000 description 1
239000010941 cobalt Substances 0.000 description 1
GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
201000007254 color blindness Diseases 0.000 description 1
230000002301 combined effect Effects 0.000 description 1
238000013170 computed tomography imaging Methods 0.000 description 1
238000011109 contamination Methods 0.000 description 1
230000008094 contradictory effect Effects 0.000 description 1
239000012050 conventional carrier Substances 0.000 description 1
229910052802 copper Inorganic materials 0.000 description 1
239000010949 copper Substances 0.000 description 1
208000029078 coronary artery disease Diseases 0.000 description 1
238000012937 correction Methods 0.000 description 1
IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 description 1
229960000258 corticotropin Drugs 0.000 description 1
229940041967 corticotropin-releasing hormone Drugs 0.000 description 1
KLVRDXBAMSPYKH-RKYZNNDCSA-N corticotropin-releasing hormone (human) Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(N)=O)[C@@H](C)CC)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H]1N(CCC1)C(=O)[C@H]1N(CCC1)C(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CO)[C@@H](C)CC)C(C)C)C(C)C)C1=CNC=N1 KLVRDXBAMSPYKH-RKYZNNDCSA-N 0.000 description 1
230000008878 coupling Effects 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
238000005859 coupling reaction Methods 0.000 description 1
238000002681 cryosurgery Methods 0.000 description 1
239000002875 cyclin dependent kinase inhibitor Substances 0.000 description 1
229940043378 cyclin-dependent kinase inhibitor Drugs 0.000 description 1
DKMKCBPTITUZRL-UHFFFAOYSA-L cyclohexane-1,2-diamine;platinum(2+);propanedioate Chemical compound [Pt+2].[O-]C(=O)CC([O-])=O.NC1CCCCC1N DKMKCBPTITUZRL-UHFFFAOYSA-L 0.000 description 1
229960004397 cyclophosphamide Drugs 0.000 description 1
ILRYLPWNYFXEMH-UHFFFAOYSA-N cystathionine Chemical compound OC(=O)C(N)CCSCC(N)C(O)=O ILRYLPWNYFXEMH-UHFFFAOYSA-N 0.000 description 1
235000018417 cysteine Nutrition 0.000 description 1
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
108010041898 cytomegalovirus receptor Proteins 0.000 description 1
210000000805 cytoplasm Anatomy 0.000 description 1
229940104302 cytosine Drugs 0.000 description 1
210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 1
229960000640 dactinomycin Drugs 0.000 description 1
230000006378 damage Effects 0.000 description 1
STQGQHZAVUOBTE-VGBVRHCVSA-N daunorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 STQGQHZAVUOBTE-VGBVRHCVSA-N 0.000 description 1
229960000975 daunorubicin Drugs 0.000 description 1
230000034994 death Effects 0.000 description 1
238000002716 delivery method Methods 0.000 description 1
210000004443 dendritic cell Anatomy 0.000 description 1
239000003599 detergent Substances 0.000 description 1
229940039227 diagnostic agent Drugs 0.000 description 1
239000000032 diagnostic agent Substances 0.000 description 1
238000000502 dialysis Methods 0.000 description 1
229960005423 diatrizoate Drugs 0.000 description 1
238000003748 differential diagnosis Methods 0.000 description 1
230000004069 differentiation Effects 0.000 description 1
UGMCXQCYOVCMTB-UHFFFAOYSA-K dihydroxy(stearato)aluminium Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[Al](O)O UGMCXQCYOVCMTB-UHFFFAOYSA-K 0.000 description 1
239000003085 diluting agent Substances 0.000 description 1
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
229960003638 dopamine Drugs 0.000 description 1
238000004980 dosimetry Methods 0.000 description 1
229960004679 doxorubicin Drugs 0.000 description 1
238000002651 drug therapy Methods 0.000 description 1
239000002961 echo contrast media Substances 0.000 description 1
230000002526 effect on cardiovascular system Effects 0.000 description 1
230000001094 effect on targets Effects 0.000 description 1
238000004520 electroporation Methods 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
230000002124 endocrine Effects 0.000 description 1
239000006274 endogenous ligand Substances 0.000 description 1
230000009762 endothelial cell differentiation Effects 0.000 description 1
ZUBDGKVDJUIMQQ-ZTNLKOGPSA-N endothelin i Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)NC(=O)[C@H]1NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CSSC[C@@H](C(N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N2)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CSSC1)C1=CNC=N1 ZUBDGKVDJUIMQQ-ZTNLKOGPSA-N 0.000 description 1
ZUBDGKVDJUIMQQ-UBFCDGJISA-N endothelin-1 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)NC(=O)[C@H]1NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](C(C)C)NC(=O)[C@H]2CSSC[C@@H](C(N[C@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N2)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](N)CSSC1)C1=CNC=N1 ZUBDGKVDJUIMQQ-UBFCDGJISA-N 0.000 description 1
239000002158 endotoxin Substances 0.000 description 1
230000002708 enhancing effect Effects 0.000 description 1
YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
IINNWAYUJNWZRM-UHFFFAOYSA-L erythrosin B Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 IINNWAYUJNWZRM-UHFFFAOYSA-L 0.000 description 1
BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
238000001704 evaporation Methods 0.000 description 1
230000008020 evaporation Effects 0.000 description 1
208000021045 exocrine pancreatic carcinoma Diseases 0.000 description 1
208000012997 experimental autoimmune encephalomyelitis Diseases 0.000 description 1
238000010195 expression analysis Methods 0.000 description 1
238000001125 extrusion Methods 0.000 description 1
229960004222 factor ix Drugs 0.000 description 1
229960000301 factor viii Drugs 0.000 description 1
230000001605 fetal effect Effects 0.000 description 1
210000003754 fetus Anatomy 0.000 description 1
229940126864 fibroblast growth factor Drugs 0.000 description 1
239000000796 flavoring agent Substances 0.000 description 1
238000013534 fluorescein angiography Methods 0.000 description 1
238000001943 fluorescence-activated cell sorting Methods 0.000 description 1
239000007850 fluorescent dye Substances 0.000 description 1
229960002949 fluorouracil Drugs 0.000 description 1
235000013355 food flavoring agent Nutrition 0.000 description 1
235000003599 food sweetener Nutrition 0.000 description 1
239000003205 fragrance Substances 0.000 description 1
239000012458 free base Substances 0.000 description 1
238000004108 freeze drying Methods 0.000 description 1
239000012520 frozen sample Substances 0.000 description 1
230000002496 gastric effect Effects 0.000 description 1
210000001035 gastrointestinal tract Anatomy 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
102000034356 gene-regulatory proteins Human genes 0.000 description 1
108091006104 gene-regulatory proteins Proteins 0.000 description 1
238000010353 genetic engineering Methods 0.000 description 1
231100000734 genotoxic potential Toxicity 0.000 description 1
MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
229960004666 glucagon Drugs 0.000 description 1
229940116332 glucose oxidase Drugs 0.000 description 1
235000019420 glucose oxidase Nutrition 0.000 description 1
235000013922 glutamic acid Nutrition 0.000 description 1
239000004220 glutamic acid Substances 0.000 description 1
229960002743 glutamine Drugs 0.000 description 1
239000002622 gonadotropin Substances 0.000 description 1
101150106093 gpt gene Proteins 0.000 description 1
239000001963 growth medium Substances 0.000 description 1
230000036541 health Effects 0.000 description 1
239000000185 hemagglutinin Substances 0.000 description 1
229940059442 hemicellulase Drugs 0.000 description 1
108010002430 hemicellulase Proteins 0.000 description 1
230000002008 hemorrhagic effect Effects 0.000 description 1
210000003494 hepatocyte Anatomy 0.000 description 1
231100000304 hepatotoxicity Toxicity 0.000 description 1
229960001340 histamine Drugs 0.000 description 1
229920001519 homopolymer Polymers 0.000 description 1
108091008039 hormone receptors Proteins 0.000 description 1
238000001794 hormone therapy Methods 0.000 description 1
210000005260 human cell Anatomy 0.000 description 1
208000033519 human immunodeficiency virus infectious disease Diseases 0.000 description 1
208000008750 humoral hypercalcemia of malignancy Diseases 0.000 description 1
229960002773 hyaluronidase Drugs 0.000 description 1
230000036571 hydration Effects 0.000 description 1
238000006703 hydration reaction Methods 0.000 description 1
150000004679 hydroxides Chemical class 0.000 description 1
239000001863 hydroxypropyl cellulose Substances 0.000 description 1
235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
206010020718 hyperplasia Diseases 0.000 description 1
230000002390 hyperplastic effect Effects 0.000 description 1
230000007954 hypoxia Effects 0.000 description 1
229960001101 ifosfamide Drugs 0.000 description 1
HOMGKSMUEGBAAB-UHFFFAOYSA-N ifosfamide Chemical compound ClCCNP1(=O)OCCCN1CCCl HOMGKSMUEGBAAB-UHFFFAOYSA-N 0.000 description 1
101150052240 ihfA gene Proteins 0.000 description 1
238000010191 image analysis Methods 0.000 description 1
210000000987 immune system Anatomy 0.000 description 1
230000003053 immunization Effects 0.000 description 1
238000002649 immunization Methods 0.000 description 1
238000010185 immunofluorescence analysis Methods 0.000 description 1
238000010569 immunofluorescence imaging Methods 0.000 description 1
230000005847 immunogenicity Effects 0.000 description 1
239000002955 immunomodulating agent Substances 0.000 description 1
230000002584 immunomodulator Effects 0.000 description 1
239000003547 immunosorbent Substances 0.000 description 1
238000012744 immunostaining Methods 0.000 description 1
238000002513 implantation Methods 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
230000002458 infectious effect Effects 0.000 description 1
230000036512 infertility Effects 0.000 description 1
208000027866 inflammatory disease Diseases 0.000 description 1
230000004054 inflammatory process Effects 0.000 description 1
206010022000 influenza Diseases 0.000 description 1
239000000893 inhibin Substances 0.000 description 1
ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 description 1
238000011081 inoculation Methods 0.000 description 1
150000007529 inorganic bases Chemical class 0.000 description 1
206010022437 insomnia Diseases 0.000 description 1
102000006495 integrins Human genes 0.000 description 1
108010044426 integrins Proteins 0.000 description 1
229940047124 interferons Drugs 0.000 description 1
108090000681 interleukin 20 Proteins 0.000 description 1
102000004114 interleukin 20 Human genes 0.000 description 1
230000008991 intestinal motility Effects 0.000 description 1
238000007917 intracranial administration Methods 0.000 description 1
239000001573 invertase Substances 0.000 description 1
235000011073 invertase Nutrition 0.000 description 1
VBUWHHLIZKOSMS-RIWXPGAOSA-N invicorp Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=C(O)C=C1 VBUWHHLIZKOSMS-RIWXPGAOSA-N 0.000 description 1
239000000193 iodinated contrast media Substances 0.000 description 1
239000011630 iodine Substances 0.000 description 1
229960001025 iohexol Drugs 0.000 description 1
NTHXOOBQLCIOLC-UHFFFAOYSA-N iohexol Chemical compound OCC(O)CN(C(=O)C)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I NTHXOOBQLCIOLC-UHFFFAOYSA-N 0.000 description 1
CANPFCFJURGKAX-JTQLQIEISA-N iolopride Chemical compound CCN1CCC[C@H]1CNC(=O)C1=C(O)C(I)=CC=C1OC CANPFCFJURGKAX-JTQLQIEISA-N 0.000 description 1
FRIZVHMAECRUBR-KIWWSDKQSA-N iomazenil ((123)I) Chemical compound C1N(C)C(=O)C2=C([123I])C=CC=C2N2C=NC(C(=O)OCC)=C21 FRIZVHMAECRUBR-KIWWSDKQSA-N 0.000 description 1
230000005865 ionizing radiation Effects 0.000 description 1
XQZXYNRDCRIARQ-LURJTMIESA-N iopamidol Chemical compound C[C@H](O)C(=O)NC1=C(I)C(C(=O)NC(CO)CO)=C(I)C(C(=O)NC(CO)CO)=C1I XQZXYNRDCRIARQ-LURJTMIESA-N 0.000 description 1
229960004647 iopamidol Drugs 0.000 description 1
229940074884 iopanoate Drugs 0.000 description 1
229940029378 iothalamate Drugs 0.000 description 1
229910052742 iron Inorganic materials 0.000 description 1
AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
229960000310 isoleucine Drugs 0.000 description 1
JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 1
230000000155 isotopic effect Effects 0.000 description 1
150000004715 keto acids Chemical class 0.000 description 1
201000006370 kidney failure Diseases 0.000 description 1
229940116108 lactase Drugs 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N lactose group Chemical group OC1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@H](O2)CO)[C@H](O1)CO GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
238000002430 laser surgery Methods 0.000 description 1
229940067606 lecithin Drugs 0.000 description 1
239000000787 lecithin Substances 0.000 description 1
235000010445 lecithin Nutrition 0.000 description 1
229940039781 leptin Drugs 0.000 description 1
NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
238000012417 linear regression Methods 0.000 description 1
235000019421 lipase Nutrition 0.000 description 1
108010013555 lipoprotein-associated coagulation inhibitor Proteins 0.000 description 1
210000005229 liver cell Anatomy 0.000 description 1
230000033001 locomotion Effects 0.000 description 1
239000000314 lubricant Substances 0.000 description 1
238000004020 luminiscence type Methods 0.000 description 1
208000037841 lung tumor Diseases 0.000 description 1
239000004325 lysozyme Substances 0.000 description 1
229960000274 lysozyme Drugs 0.000 description 1
235000010335 lysozyme Nutrition 0.000 description 1
210000002540 macrophage Anatomy 0.000 description 1
230000005415 magnetization Effects 0.000 description 1
230000014759 maintenance of location Effects 0.000 description 1
229940107698 malachite green Drugs 0.000 description 1
FDZZZRQASAIRJF-UHFFFAOYSA-M malachite green Chemical compound [Cl-].C1=CC(N(C)C)=CC=C1C(C=1C=CC=CC=1)=C1C=CC(=[N+](C)C)C=C1 FDZZZRQASAIRJF-UHFFFAOYSA-M 0.000 description 1
230000007257 malfunction Effects 0.000 description 1
230000003211 malignant effect Effects 0.000 description 1
229910052748 manganese Inorganic materials 0.000 description 1
239000011572 manganese Substances 0.000 description 1
229960004961 mechlorethamine Drugs 0.000 description 1
HAWPXGHAZFHHAD-UHFFFAOYSA-N mechlorethamine Chemical compound ClCCN(C)CCCl HAWPXGHAZFHHAD-UHFFFAOYSA-N 0.000 description 1
239000008155 medical solution Substances 0.000 description 1
210000002752 melanocyte Anatomy 0.000 description 1
229960001924 melphalan Drugs 0.000 description 1
SGDBTWWWUNNDEQ-LBPRGKRZSA-N melphalan Chemical compound OC(=O)[C@@H](N)CC1=CC=C(N(CCCl)CCCl)C=C1 SGDBTWWWUNNDEQ-LBPRGKRZSA-N 0.000 description 1
210000004779 membrane envelope Anatomy 0.000 description 1
102000006240 membrane receptors Human genes 0.000 description 1
108020004084 membrane receptors Proteins 0.000 description 1
210000003716 mesoderm Anatomy 0.000 description 1
230000002503 metabolic effect Effects 0.000 description 1
230000001394 metastastic effect Effects 0.000 description 1
206010061289 metastatic neoplasm Diseases 0.000 description 1
229930182817 methionine Natural products 0.000 description 1
125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 1
229960000485 methotrexate Drugs 0.000 description 1
CWWARWOPSKGELM-SARDKLJWSA-N methyl (2s)-2-[[(2s)-2-[[2-[[(2s)-2-[[(2s)-2-[[(2s)-5-amino-2-[[(2s)-5-amino-2-[[(2s)-1-[(2s)-6-amino-2-[[(2s)-1-[(2s)-2-amino-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-5 Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)OC)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CCCN=C(N)N)C1=CC=CC=C1 CWWARWOPSKGELM-SARDKLJWSA-N 0.000 description 1
235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
HPNSFSBZBAHARI-UHFFFAOYSA-N micophenolic acid Natural products OC1=C(CC=C(C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-UHFFFAOYSA-N 0.000 description 1
238000000520 microinjection Methods 0.000 description 1
239000011859 microparticle Substances 0.000 description 1
239000004005 microsphere Substances 0.000 description 1
230000003278 mimic effect Effects 0.000 description 1
229960004857 mitomycin Drugs 0.000 description 1
SLZIZIJTGAYEKK-CIJSCKBQSA-N molport-023-220-247 Chemical compound C([C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)CN)[C@@H](C)O)C1=CNC=N1 SLZIZIJTGAYEKK-CIJSCKBQSA-N 0.000 description 1
229950009740 molybdenum mo-99 Drugs 0.000 description 1
230000000877 morphologic effect Effects 0.000 description 1
238000010172 mouse model Methods 0.000 description 1
201000006417 multiple sclerosis Diseases 0.000 description 1
230000035772 mutation Effects 0.000 description 1
229960000951 mycophenolic acid Drugs 0.000 description 1
HPNSFSBZBAHARI-RUDMXATFSA-N mycophenolic acid Chemical compound OC1=C(C\C=C(/C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-RUDMXATFSA-N 0.000 description 1
239000002077 nanosphere Substances 0.000 description 1
210000000822 natural killer cell Anatomy 0.000 description 1
229940086322 navelbine Drugs 0.000 description 1
230000017074 necrotic cell death Effects 0.000 description 1
230000024717 negative regulation of secretion Effects 0.000 description 1
101150091879 neo gene Proteins 0.000 description 1
230000001613 neoplastic effect Effects 0.000 description 1
230000004770 neurodegeneration Effects 0.000 description 1
208000015122 neurodegenerative disease Diseases 0.000 description 1
238000002610 neuroimaging Methods 0.000 description 1
239000003176 neuroleptic agent Substances 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
229920001220 nitrocellulos Polymers 0.000 description 1
231100000957 no side effect Toxicity 0.000 description 1
238000012633 nuclear imaging Methods 0.000 description 1
URPYMXQQVHTUDU-OFGSCBOVSA-N nucleopeptide y Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 URPYMXQQVHTUDU-OFGSCBOVSA-N 0.000 description 1
239000002777 nucleoside Substances 0.000 description 1
125000003835 nucleoside group Chemical group 0.000 description 1
235000015097 nutrients Nutrition 0.000 description 1
235000016709 nutrition Nutrition 0.000 description 1
238000002515 oligonucleotide synthesis Methods 0.000 description 1
230000000771 oncological effect Effects 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
150000007530 organic bases Chemical class 0.000 description 1
230000008520 organization Effects 0.000 description 1
230000002138 osteoinductive effect Effects 0.000 description 1
230000002611 ovarian Effects 0.000 description 1
230000002018 overexpression Effects 0.000 description 1
230000003647 oxidation Effects 0.000 description 1
238000007254 oxidation reaction Methods 0.000 description 1
XNOPRXBHLZRZKH-DSZYJQQASA-N oxytocin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@H](N)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 XNOPRXBHLZRZKH-DSZYJQQASA-N 0.000 description 1
229960001723 oxytocin Drugs 0.000 description 1
238000004806 packaging method and process Methods 0.000 description 1
229960001592 paclitaxel Drugs 0.000 description 1
238000011499 palliative surgery Methods 0.000 description 1
RYZUEKXRBSXBRH-CTXORKPYSA-N pancreastatin Chemical compound C([C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)CN)CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(N)=O)C1=CN=CN1 RYZUEKXRBSXBRH-CTXORKPYSA-N 0.000 description 1
239000012188 paraffin wax Substances 0.000 description 1
229920002866 paraformaldehyde Polymers 0.000 description 1
239000000199 parathyroid hormone Substances 0.000 description 1
229960001319 parathyroid hormone Drugs 0.000 description 1
230000037361 pathway Effects 0.000 description 1
108020004410 pectinesterase Proteins 0.000 description 1
210000004197 pelvis Anatomy 0.000 description 1
229940049954 penicillin Drugs 0.000 description 1
239000000813 peptide hormone Substances 0.000 description 1
239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
230000035699 permeability Effects 0.000 description 1
108040007629 peroxidase activity proteins Proteins 0.000 description 1
239000008194 pharmaceutical composition Substances 0.000 description 1
239000000546 pharmaceutical excipient Substances 0.000 description 1
239000000825 pharmaceutical preparation Substances 0.000 description 1
238000009520 phase I clinical trial Methods 0.000 description 1
229960003742 phenol Drugs 0.000 description 1
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
150000003905 phosphatidylinositols Chemical class 0.000 description 1
150000003904 phospholipids Chemical class 0.000 description 1
230000026731 phosphorylation Effects 0.000 description 1
238000006366 phosphorylation reaction Methods 0.000 description 1
230000001817 pituitary effect Effects 0.000 description 1
239000000902 placebo Substances 0.000 description 1
229940068196 placebo Drugs 0.000 description 1
BLFWHYXWBKKRHI-JYBILGDPSA-N plap Chemical compound N([C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@@H](N)CCC(O)=O BLFWHYXWBKKRHI-JYBILGDPSA-N 0.000 description 1
229910052697 platinum Inorganic materials 0.000 description 1
229920001308 poly(aminoacid) Polymers 0.000 description 1
229920001223 polyethylene glycol Polymers 0.000 description 1
238000003752 polymerase chain reaction Methods 0.000 description 1
YPHQRHBJEUDWJW-UHFFFAOYSA-N porphobilinogen Chemical compound NCC1=NC=C(CCC(O)=O)[C]1CC(O)=O YPHQRHBJEUDWJW-UHFFFAOYSA-N 0.000 description 1
239000013641 positive control Substances 0.000 description 1
230000029279 positive regulation of transcription, DNA-dependent Effects 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
239000011591 potassium Substances 0.000 description 1
230000003389 potentiating effect Effects 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
239000002243 precursor Substances 0.000 description 1
239000002987 primer (paints) Substances 0.000 description 1
238000007639 printing Methods 0.000 description 1
MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
229960004919 procaine Drugs 0.000 description 1
229960000624 procarbazine Drugs 0.000 description 1
CPTBDICYNRMXFX-UHFFFAOYSA-N procarbazine Chemical compound CNNCC1=CC=C(C(=O)NC(C)C)C=C1 CPTBDICYNRMXFX-UHFFFAOYSA-N 0.000 description 1
238000012545 processing Methods 0.000 description 1
230000005522 programmed cell death Effects 0.000 description 1
230000002035 prolonged effect Effects 0.000 description 1
230000001737 promoting effect Effects 0.000 description 1
238000011321 prophylaxis Methods 0.000 description 1
235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
108010087851 prorelaxin Proteins 0.000 description 1
150000003180 prostaglandins Chemical class 0.000 description 1
235000019833 protease Nutrition 0.000 description 1
235000019419 proteases Nutrition 0.000 description 1
108020001580 protein domains Proteins 0.000 description 1
238000000164 protein isolation Methods 0.000 description 1
108060006633 protein kinase Proteins 0.000 description 1
108020000494 protein-tyrosine phosphatase Proteins 0.000 description 1
XNSAINXGIQZQOO-SRVKXCTJSA-N protirelin Chemical compound NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H]1NC(=O)CC1)CC1=CN=CN1 XNSAINXGIQZQOO-SRVKXCTJSA-N 0.000 description 1
IGFXRKMLLMBKSA-UHFFFAOYSA-N purine Chemical compound N1=C[N]C2=NC=NC2=C1 IGFXRKMLLMBKSA-UHFFFAOYSA-N 0.000 description 1
239000002510 pyrogen Substances 0.000 description 1
239000013608 rAAV vector Substances 0.000 description 1
239000000941 radioactive substance Substances 0.000 description 1
229940075621 radiolabeled somatostatin analogue Drugs 0.000 description 1
GZUITABIAKMVPG-UHFFFAOYSA-N raloxifene Chemical compound C1=CC(O)=CC=C1C1=C(C(=O)C=2C=CC(OCCN3CCCCC3)=CC=2)C2=CC=C(O)C=C2S1 GZUITABIAKMVPG-UHFFFAOYSA-N 0.000 description 1
229960004622 raloxifene Drugs 0.000 description 1
238000009790 rate-determining step (RDS) Methods 0.000 description 1
230000008707 rearrangement Effects 0.000 description 1
230000009467 reduction Effects 0.000 description 1
238000000611 regression analysis Methods 0.000 description 1
230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
230000027425 release of sequestered calcium ion into cytosol Effects 0.000 description 1
239000003488 releasing hormone Substances 0.000 description 1
230000008439 repair process Effects 0.000 description 1
230000003362 replicative effect Effects 0.000 description 1
238000010839 reverse transcription Methods 0.000 description 1
238000009738 saturating Methods 0.000 description 1
201000000980 schizophrenia Diseases 0.000 description 1
210000003497 sciatic nerve Anatomy 0.000 description 1
238000012216 screening Methods 0.000 description 1
229960002101 secretin Drugs 0.000 description 1
OWMZNFCDEHGFEP-NFBCVYDUSA-N secretin human Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(N)=O)[C@@H](C)O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)C1=CC=CC=C1 OWMZNFCDEHGFEP-NFBCVYDUSA-N 0.000 description 1
230000003248 secreting effect Effects 0.000 description 1
229910052711 selenium Inorganic materials 0.000 description 1
239000011669 selenium Substances 0.000 description 1
230000009758 senescence Effects 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
238000000926 separation method Methods 0.000 description 1
229940076279 serotonin Drugs 0.000 description 1
125000005630 sialyl group Chemical group 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
239000011734 sodium Substances 0.000 description 1
239000007787 solid Substances 0.000 description 1
235000010199 sorbic acid Nutrition 0.000 description 1
239000004334 sorbic acid Substances 0.000 description 1
229940075582 sorbic acid Drugs 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
238000011301 standard therapy Methods 0.000 description 1
239000007858 starting material Substances 0.000 description 1
230000003068 static effect Effects 0.000 description 1
238000007619 statistical method Methods 0.000 description 1
230000001954 sterilising effect Effects 0.000 description 1
238000004659 sterilization and disinfection Methods 0.000 description 1
230000004936 stimulating effect Effects 0.000 description 1
238000003860 storage Methods 0.000 description 1
229960005322 streptomycin Drugs 0.000 description 1
230000035882 stress Effects 0.000 description 1
238000010254 subcutaneous injection Methods 0.000 description 1
239000007929 subcutaneous injection Substances 0.000 description 1
235000000346 sugar Nutrition 0.000 description 1
150000008163 sugars Chemical class 0.000 description 1
238000011477 surgical intervention Methods 0.000 description 1
239000000725 suspension Substances 0.000 description 1
239000003765 sweetening agent Substances 0.000 description 1
230000005062 synaptic transmission Effects 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
238000007910 systemic administration Methods 0.000 description 1
238000012385 systemic delivery Methods 0.000 description 1
231100000057 systemic toxicity Toxicity 0.000 description 1
101150047061 tag-72 gene Proteins 0.000 description 1
229960001603 tamoxifen Drugs 0.000 description 1
RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 1
229940056501 technetium 99m Drugs 0.000 description 1
RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
229940033663 thimerosal Drugs 0.000 description 1
239000010409 thin film Substances 0.000 description 1
229960004072 thrombin Drugs 0.000 description 1
229940104230 thymidine Drugs 0.000 description 1
229940113082 thymine Drugs 0.000 description 1
229940034199 thyrotropin-releasing hormone Drugs 0.000 description 1
229940034208 thyroxine Drugs 0.000 description 1
XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 1
108091006106 transcriptional activators Proteins 0.000 description 1
230000014616 translation Effects 0.000 description 1
150000003626 triacylglycerols Chemical class 0.000 description 1
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
230000010415 tropism Effects 0.000 description 1
230000005909 tumor killing Effects 0.000 description 1
238000013042 tunel staining Methods 0.000 description 1
238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
238000009827 uniform distribution Methods 0.000 description 1
229940035893 uracil Drugs 0.000 description 1
230000002485 urinary effect Effects 0.000 description 1
229960005486 vaccine Drugs 0.000 description 1
208000007089 vaccinia Diseases 0.000 description 1
238000001291 vacuum drying Methods 0.000 description 1
239000004474 valine Substances 0.000 description 1
235000015112 vegetable and seed oil Nutrition 0.000 description 1
239000008158 vegetable oil Substances 0.000 description 1
JXLYSJRDGCGARV-CFWMRBGOSA-N vinblastine Chemical compound C([C@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 JXLYSJRDGCGARV-CFWMRBGOSA-N 0.000 description 1
229960003048 vinblastine Drugs 0.000 description 1
229960004528 vincristine Drugs 0.000 description 1
OGWKCGZFUXNPDA-XQKSVPLYSA-N vincristine Chemical compound C([N@]1C[C@@H](C[C@]2(C(=O)OC)C=3C(=CC4=C([C@]56[C@H]([C@@]([C@H](OC(C)=O)[C@]7(CC)C=CCN([C@H]67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)C[C@@](C1)(O)CC)CC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-XQKSVPLYSA-N 0.000 description 1
OGWKCGZFUXNPDA-UHFFFAOYSA-N vincristine Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(OC(C)=O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-UHFFFAOYSA-N 0.000 description 1
CILBMBUYJCWATM-PYGJLNRPSA-N vinorelbine ditartrate Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O.OC(=O)[C@H](O)[C@@H](O)C(O)=O.C1N(CC=2C3=CC=CC=C3NC=22)CC(CC)=C[C@H]1C[C@]2(C(=O)OC)C1=CC([C@]23[C@H]([C@@]([C@H](OC(C)=O)[C@]4(CC)C=CCN([C@H]34)CC2)(O)C(=O)OC)N2C)=C2C=C1OC CILBMBUYJCWATM-PYGJLNRPSA-N 0.000 description 1
238000012800 visualization Methods 0.000 description 1
210000005253 yeast cell Anatomy 0.000 description 1
239000001043 yellow dye Substances 0.000 description 1